var title_f24_22_24928="External rotation technique for shoulder reduction";
var content_f24_22_24928=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/81132/External_rotation.mp4?title=External+rotation+technique+for+shoulder+reduction\" style=\"width:448px;height:352px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    External rotation technique for reducing anterior shoulder dislocation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The external rotation technique can be used to reduce anterior glenohumeral (shoulder) dislocations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Simon and Sherman, Emergency Orthopedics, 6th edition. DVD &copy; Scott Sherman. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24928=[""].join("\n");
var outline_f24_22_24928=null;
var title_f24_22_24929="Pedunculated polyp endloop";
var content_f24_22_24929=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59681&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Colonic polypectomy using an endoloop",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Pedunculated polyp with a broad thick stalk; (B) Endoloop placed on the base of the polyp; (C) Polyp being transected with a snare placed above the endoloop.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jerome D Waye, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24929=[""].join("\n");
var outline_f24_22_24929=null;
var title_f24_22_24930="Atypical pneumothorax CT";
var content_f24_22_24930=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59597&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Atypical pneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic atypical pneumothorax in patient with known rheumatoid arthritis, bibasilar pulmonary fibrosis, and left pleural effusion. Chest radiograph (left panel) shows right infero-lateral collection of intrapleural gas with an atypical concave pleural edge toward the chest wall and the costophrenic sulcus. CT scan (right panel) shows right basilar hydropneumothorax and the collapsed right lower lung with a thickened visceral pleura.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24930=[""].join("\n");
var outline_f24_22_24930=null;
var title_f24_22_24931="ECG sinus node dysfunction";
var content_f24_22_24931=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    ECG of sinus node dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 221px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The continuous lead V2 rhythm strip shows evidence of sinus node dysfunction. Following the third sinus beat (*) there is a pause followed by the occurrence of an escape junctional rhythm at a slower rate. P waves reappear (arrows), which are initally dissociated from the QRS complex, but ultimately they become associated with the QRS, resulting in 1:1 conduction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission by Samuel Levy, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24931=[""].join("\n");
var outline_f24_22_24931=null;
var title_f24_22_24932="Aprepitant: Patient drug information";
var content_f24_22_24932=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aprepitant: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/28/33222?source=see_link\">",
"     see \"Aprepitant: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/46/38630?source=see_link\">",
"     see \"Aprepitant: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Emend&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5498119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Emend&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691478",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop upset stomach and throwing up.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aprepitant or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698131",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hiccups.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018515\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696141",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To stop upset stomach from chemo, take first dose 1 hour before chemo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696144",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To stop upset stomach from surgery, take this drug 3 hours before surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11166 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-6720EAAD2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24932=[""].join("\n");
var outline_f24_22_24932=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136348\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5498119\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018506\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018508\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018507\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018512\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018513\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018515\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018510\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018511\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018516\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018517\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/28/33222?source=related_link\">",
"      Aprepitant: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/46/38630?source=related_link\">",
"      Aprepitant: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_22_24933="Magnesium chloride: Drug information";
var content_f24_22_24933=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Magnesium chloride: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/28/24004?source=see_link\">",
"    see \"Magnesium chloride: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/31/501?source=see_link\">",
"    see \"Magnesium chloride: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Chloromag&reg;;",
"     </li>",
"     <li>",
"      Mag 64&reg; [OTC];",
"     </li>",
"     <li>",
"      Mag Delay&trade; [OTC];",
"     </li>",
"     <li>",
"      Slow-Mag&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F190792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Electrolyte Supplement, Oral;",
"     </li>",
"     <li>",
"      Electrolyte Supplement, Parenteral;",
"     </li>",
"     <li>",
"      Magnesium Salt",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F190784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Serum magnesium is poor reflection of repletional status as the majority of magnesium is intracellular; serum levels may be transiently normal for a few hours after a dose is given; therefore, aim for consistently high normal serum levels in patients with normal renal function for most efficient repletion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dietary supplement:",
"     </b>",
"     Oral (Mag 64&reg;, Mag Delay&trade;, Slow-Mag&reg;): 2 tablets once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition supplementation:",
"     </b>",
"     I.V. (elemental magnesium): 8-24 mEq/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      RDA (elemental magnesium) (IOM, 1997):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     19-30 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Females: 310 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pregnancy: 350 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lactation: 310 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Males: 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &ge;31 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Females: 320 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pregnancy: 360 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lactation: 320 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Males: 420 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F190789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/31/501?source=see_link\">",
"      see \"Magnesium chloride: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Serum magnesium is poor reflection of repletional status as the majority of magnesium is intracellular; serum levels may be transiently normal for a few hours after a dose is given; therefore, aim for consistently high normal serum levels in patients with normal renal function for most efficient repletion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition supplementation:",
"     </b>",
"     I.V. (elemental magnesium):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &lt;50 kg: 0.3-0.5 mEq/kg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;50 kg: 10-30 mEq/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      RDA (elemental magnesium) (IOM, 1997):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-3 years: 80 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-8 years: 130 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     9-13 years: 240 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     14-18 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Females: 360 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Pregnancy: 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lactation: 360 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Males: 410 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F190785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F190786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: Use with caution; monitor for hypermagnesemia",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16317810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hexahydrate: 200 mg/mL (50 mL) [equivalent to elemental magnesium 1.97 mEq/mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chloromag&reg;: 200 mg/mL (50 mL) [contains aluminum, benzyl alcohol; equivalent to elemental magnesium 1.97 mEq/mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, delayed release, enteric coated, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mag 64&reg;: Elemental magnesium 64 mg [sugar free; contains elemental calcium 112 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mag Delay&trade;: Elemental magnesium 64 mg [contains elemental calcium 112 mg]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, enteric coated, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Slow-Mag&reg;: Elemental magnesium 71.5 mg [contains elemental calcium 119 mg]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F190779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Correction or prevention of hypomagnesemia; dietary supplement",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F190790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not defined: Gastrointestinal: Diarrhea (excessive oral doses)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F3011370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypersensitivity to any component of the formulation; renal impairment; myocardial disease; coma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F3011371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuromuscular disease: Use with extreme caution in patients with myasthenia gravis or other neuromuscular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; accumulation of magnesium may lead to magnesium intoxication.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Obstetrics: Vigilant monitoring and safe administration techniques (ISMP Medication Safety Alert, 2005) recommended to avoid potential for errors resulting in toxicity. Monitor patient and fetal status, and serum magnesium levels closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aluminum: Solutions may contain aluminum; toxic levels may occur following prolonged administration in premature neonates or patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte abnormalities:  Concurrent hypokalemia or hypocalcemia can accompany a magnesium deficit. Hypomagnesemia is associated with hypokalemia and requires correction in order to normalize potassium.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Parenteral administration: Monitor serum magnesium level, respiratory rate, blood pressure, deep tendon reflex, and renal function when administered parenterally, particularly with repeated dosing; magnesium toxicity can lead to fatal cardiovascular arrest and/or respiratory paralysis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F3011375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfacalcidol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Magnesium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral magnesium salts within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcitriol: May increase the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: May enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Magnesium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Magnesium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., magnesium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Magnesium Salts may decrease the serum concentration of Mycophenolate.  Management: Separate doses of mycophenolate and oral magnesium salts. Monitor for reduced effects of mycophenolate if taken concomitant with oral magnesium salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents: Magnesium Salts may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Magnesium Salts may decrease the serum concentration of Phosphate Supplements.  Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral magnesium salt administration.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Magnesium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Magnesium Salts may decrease the absorption of Tetracycline Derivatives. Only applicable to oral preparations of each agent.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Magnesium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Magnesium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F190774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3011366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Animal reproduction studies have not been conducted. Magnesium crosses the placenta; serum levels in the fetus correlate with those in the mother (Idama, 1998; Osada, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F3011368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Enters breast milk",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F3011369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Magnesium is found in breast milk; concentrations remain constant during the first year of lactation and are not influenced by dietary intake under normal conditions. Magnesium requirements are the same in lactating and non-lactating females (IOM, 1997).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F3011754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Whole grains, legumes, and dark-green leafy vegetables are dietary sources of magnesium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F190781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Magnesium Chloride Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg/mL (50 mL): $12.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Mag-SR Plus Calcium Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     535 (64 Mg) mg (60): $7.99",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Mag64 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     535 (64 Mg) mg (60): $8.65",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, EC",
"     </b>",
"     (Slow-Mag Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     71.5-119 mg (60): $10.25",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3011755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Rapid administration: ECG monitoring, vital signs, deep tendon reflexes; magnesium, calcium, and potassium levels; renal function during administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Renal function; magnesium levels; bowel movements",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F190778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum magnesium: 1.5-2.5 mg/dL; slightly different ranges are reported by different laboratories",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4088912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Slow-Mag (PL);",
"     </li>",
"     <li>",
"      Solural (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F3011747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Magnesium is important as a cofactor in many enzymatic reactions in the body involving protein synthesis and carbohydrate metabolism (at least 300 enzymatic reactions require magnesium). Actions on lipoprotein lipase have been found to be important in reducing serum cholesterol and on sodium/potassium ATPase in promoting polarization (eg, neuromuscular functioning).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F3011749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Inversely proportional to amount ingested; 40% to 60% under controlled dietary conditions; 15% to 36% at higher doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Bone (50% to 60%); extracellular fluid (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 30%, to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (as magnesium)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bashuk RG and Krendel DA, &ldquo;Myasthenia Gravis Presenting as Weakness After Magnesium Administration,&rdquo;",
"      <i>",
"       Muscle Nerve",
"      </i>",
"      , 1990, 13(8):708-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/22/24933/abstract-text/2385256/pubmed\" id=\"2385256\" target=\"_blank\">",
"        2385256",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chernow B, Smith J, Rainey TG, et al, &ldquo;Hypomagnesemia: Implications for the Critical Care Specialist,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1982, 10(3):193-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/22/24933/abstract-text/7037303/pubmed\" id=\"7037303\" target=\"_blank\">",
"        7037303",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dube L and Granry JC, &ldquo;The Therapeutic Use Of Magnesium In Anesthesiology, Intensive Care And Emergency Medicine: A Review,&rdquo;",
"      <i>",
"       Can J Anaesth",
"      </i>",
"      , 2003, 50(7):732-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/22/24933/abstract-text/12944451/pubmed\" id=\"12944451\" target=\"_blank\">",
"        12944451",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gams JG, &ldquo;Clinical Significance of Magnesium: A Review,&rdquo;",
"      <i>",
"       Drug Intell Clin Pharm",
"      </i>",
"      , 1987, 21(3):240-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/22/24933/abstract-text/3552543/pubmed\" id=\"3552543\" target=\"_blank\">",
"        3552543",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Idama TO and Lindow SW, &ldquo;Magnesium Sulphate: A Review of Clinical Pharmacology Applied to Obstetrics,&rdquo;",
"      <i>",
"       Br J Obstet Gynaecol",
"      </i>",
"      , 1998, 105(3):260-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride",
"      </i>",
"      , National Academy of Sciences, Washington, DC, 1997.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mirtallo J, Canada T, Johnson D, et al, &ldquo;Safe Practices for Parenteral Nutrition,&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2004, 28(6):39-70.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Osada H, Watanabe Y, Nishimura Y, at al, \"Profile of Trace Element Concentrations in the Feto-Placental Unit in Relation to Fetal Growth,\"",
"      <i>",
"       Acta Obstet Gynecol Scand",
"      </i>",
"      , 2002, 81(10):931-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/22/24933/abstract-text/12366483/pubmed\" id=\"12366483\" target=\"_blank\">",
"        12366483",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10122 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-869C284B9E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24933=[""].join("\n");
var outline_f24_22_24933=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190783\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190792\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190784\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190789\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190785\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190786\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16317810\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190777\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190767\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190779\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190790\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011370\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011371\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299630\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011375\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190774\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011366\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011368\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011369\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011754\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190781\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011755\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190778\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4088912\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011747\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3011749\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10122\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10122|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/28/24004?source=related_link\">",
"      Magnesium chloride: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/31/501?source=related_link\">",
"      Magnesium chloride: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_22_24934="Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies";
var content_f24_22_24934=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Ethics in the intensive care unit: Responding to requests for futile or potentially inappropriate therapies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24934/contributors\">",
"     John A Kellum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Douglas B White, MD, MAS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24934/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/22/24934/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H5034227\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surrogate decision makers for patients with advanced critical illness sometimes request therapies that clinicians believe are either futile or potentially inappropriate. Such requests usually arise in two contexts. The surrogate may request a therapy that they heard about from another source, such as a friend or the internet. Alternatively, surrogates may request the continuation of a therapy that was initiated with the hope that the patient would benefit, but it subsequently became clear that the intervention was failing to meet the patient&rsquo;s goals of care. Requests for futile or potentially inappropriate treatment often arise because of poor clinician-family communication. Less commonly, they arise because of major value differences between the patient or surrogate and the clinical team.",
"   </p>",
"   <p>",
"    Issues related to requests for futile or potentially inappropriate therapies are reviewed here. Family meetings, the setting in which clinicians and surrogates often make treatment decisions, are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/40/12938?source=see_link\">",
"     \"Communication in the ICU: Holding a family meeting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034234\">",
"    <span class=\"h1\">",
"     DEFINITIONS OF FUTILE AND POTENTIALLY INAPPROPRIATE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important for clinicians to recognize that futile treatment and potentially inappropriate treatment are different:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term &ldquo;futile treatment&rdquo; should only be used to describe interventions that cannot accomplish the patient&rsquo;s medical goals, goals that are determined through careful discussions with the patient or his or her surrogates [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/1\">",
"       1",
"      </a>",
"      ]. Interventions that are unlikely to achieve the intended goal should not be labeled as futile, nor should treatments that the physician believes have an unfavorable risk-benefit ratio. It is important to note that very few conflicts in ICUs arise because of requests for futile treatments.",
"     </li>",
"     <li>",
"      The term &ldquo;potentially inappropriate&rdquo; should be used to describe treatments that are exceedingly unlikely to accomplish the patient&rsquo;s goals, intended to achieve a goal that is contrary to the clinician&rsquo;s professional integrity, or an unfair allocation of scarce resources [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Distinguishing between treatments that",
"    <strong>",
"     cannot work",
"    </strong>",
"    and treatments that",
"    <strong>",
"     could conceivably work but, nonetheless, should not be pursued",
"    </strong>",
"    is important because the latter involves complex value judgments for which there are often not clearly articulated rules to guide practice. These judgments are complex because there are diverse conceptions of what gives life meaning within pluralistic societies and, consequently, there are diverse opinions about what goals should be pursued near the end of life [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. &ldquo;Pluralism means that in the public realm there is no single measure of what is beneficial or not, valuable or not; such judgments are relative to particular conceptions of the meaning and ultimate ends of human life&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/4\">",
"     4",
"    </a>",
"    ]. As an example, a clinician may believe that the most respectful way to care for a patient with advanced dementia and multi-organ failure is to pursue a course of treatment focused on comfort, without the use of life prolonging therapies. However, a surrogate may rationally believe that the best way to respect the patient&rsquo;s values is to attempt to extend the patient&rsquo;s life through the use of life support.",
"   </p>",
"   <p>",
"    In contrast to the term &ldquo;futile&rdquo;, the term &ldquo;potentially inappropriate&rdquo; makes explicit that these determinations hinge on value judgments about what is appropriate, rather than on purely scientific judgments. These types of judgments are not &ldquo;value free&rdquo; and, in the absence of explicit, widely accepted practice standards, require special scrutiny and a careful approach to conflict resolution. In general, when a clinician judges a particular course of treatment to be inappropriate, this judgment should be treated as preliminary. Rather than acting unilaterally, these judgments should be evaluated through a process of dispute resolution that enlists diverse input.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034241\">",
"    <span class=\"h1\">",
"     PREVENTING INTRACTABLE CONFLICTS ABOUT FUTILE OR POTENTIALLY INAPPROPRIATE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is valuable to attempt to minimize conflicts about futile or potentially inappropriate treatment through preventative efforts because such conflicts are associated with negative outcomes for both clinicians and surrogates in ICUs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Most",
"    <em>",
"    </em>",
"    clinician-surrogate disagreements in ICUs arise not from profound value conflicts, but from inadequate communication and support in the face of the emotional and psychological difficulty of facing death. &nbsp;",
"   </p>",
"   <p>",
"    The decision-making process should be collaborative, involving members of the health care team, the patient, and when appropriate, the patient's surrogate or involved family members (",
"    <a class=\"graphic graphic_algorithm graphicRef81250 \" href=\"UTD.htm?28/35/29246\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/8\">",
"     8",
"    </a>",
"    ]. The initial step is to carefully define the patient&rsquo;s medical situation and prognosis. Once the clinician has established that the patient or surrogate has a reasonable understanding of the patient&rsquo;s condition and prognosis, the clinician should seek to understand the patient&rsquo;s health related values and collaboratively determine the patient&rsquo;s goals. Examples of goals include restoring health, extending life, relieving pain and suffering, and ensuring a peaceful death. &nbsp;",
"   </p>",
"   <p>",
"    Once the goals are agreed upon, the clinician should consider what therapeutic options exist that could achieve the goals of care. Therapies that cannot achieve the goals of care should be considered futile and should not be offered. Requested therapies that may achieve the goals of care and whose desirable consequences outweigh the undesirable consequences (as agreed by the patient or surrogate and the clinicians) may be administered. Therapies whose undesirable consequences outweigh the desirable consequences (as judged by the patient or surrogate and the clinicians) should not be administered. &nbsp;",
"   </p>",
"   <p>",
"    Occasionally, clinicians and patients or their surrogates disagree about whether the risks of harm outweigh the chance of benefit. When clinicians believe that continued ICU treatment is inappropriate for a patient with a very poor prognosis, they should empathically discuss this with the surrogate, provide recommendations, and explain the reasons underlying their recommendations. The goal of this discussion should be to foster a dialogue in which the values and goals of both sides are explored. Empirical research suggests that most clinician-surrogate conflicts are not intractable and can be resolved collaboratively through ongoing dialogue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] or with the help of communication experts, such as ethics or palliative care consultants [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/11-15\">",
"     11-15",
"    </a>",
"    ]. Family meetings, the setting in which clinicians and surrogates often make treatment decisions, are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/40/12938?source=see_link\">",
"     \"Communication in the ICU: Holding a family meeting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034248\">",
"    <span class=\"h1\">",
"     RESPONDING TO REQUESTS FOR FUTILE TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is widespread agreement that clinicians need not provide futile treatments because doing so goes against the most basic ethical obligations of physicians to act to benefit their individual patients and refrain from harming their patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/1,16\">",
"     1,16",
"    </a>",
"    ]. Prospective review of such refusals should not be required for two reasons. First, determinations of futility are technical judgments that hinge on knowledge of disease pathophysiology and treatment efficacy, rather than complex value judgments about whether the patient&rsquo;s goals are appropriate or whether the risks of treatment have a &lsquo;reasonable&rsquo; burden-benefit ratio. Second, requiring prospective review of all futility determinations in ICUs would be logistically problematic because such requests often arise in highly time-constrained circumstances when patients are actively dying. Requiring prospective review would frequently lead to situations in which clinicians were required to administer the futile treatments in the interim and therefore violate their professional ethical obligations not to provide ineffective therapies. Instead, we suggest retrospective review of such cases, which can help clinicians and institutions incrementally improve the skill with which they respond to such requests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034255\">",
"    <span class=\"h1\">",
"     RESPONDING TO REQUESTS FOR POTENTIALLY INAPPROPRIATE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinician&rsquo;s initial response to a request for potentially inappropriate treatment should be intensive efforts to find a negotiated agreement, through both dialogue with the family and the involvement of communication experts such as hospital ethics committees, palliative care consultants, or mediation experts [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/17\">",
"     17",
"    </a>",
"    ]. If a mutually acceptable treatment plan cannot be found, there should be a fair process of dispute resolution. It is ethically problematic for clinicians to simply acquiesce to requests for treatments that they believe are outside the boundaries of acceptable medical practice. It is also ethically problematic for clinicians to unilaterally refuse to provide the requested treatment without a fair decision making process when there is uncertainty about what is the boundary of acceptable medical practice. These recommendations mirror those from the American Medical Association [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/18\">",
"     18",
"    </a>",
"    ] and the Society for Critical Care Medicine [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034262\">",
"    <span class=\"h2\">",
"     Recommended approach to dispute resolution",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest a six step process to manage requests for potentially inappropriate treatment that persist despite intensive communication and multiple attempts to find a negotiated agreement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inform the surrogate about the dispute resolution process &ndash; The surrogate should be informed that a process-based resolution procedure has been initiated. They should also be informed about the steps involved in such a process, and the anticipated timeline. &nbsp;",
"     </li>",
"     <li>",
"      Request review by a multidisciplinary hospital committee &ndash; The clinical team should request that the case be reviewed by a multidisciplinary hospital committee, usually the hospital ethics committee. The purpose of this step is to determine whether the treating team&rsquo;s opinion that the requested therapies are inappropriate is shared by individuals with diverse clinical expertise as well as bioethics expertise. The committee should be interprofessional in nature and should strive to have community representation. The opinions of the committee should be provided to the surrogate in writing, and should include reasons for the decision. Providing reasons for the decision &ldquo;leads to fairer decisions over time for two reasons. First, formal requirements of fairness are better met since there is consistent treatment of similar cases. Second, the discipline involved in specifying the appropriate reasons and making sure they really bear on the case promotes thoughtful evaluation of these reasons and their foundations within our thinking. To the extent that we are then better able to discover flaws in our moral reasoning, we are more likely to reach fair decisions&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Continue dialogue between the clinical team and surrogate &ndash; An important goal of the dispute resolution process is to encourage clinicians and surrogates to iteratively reconsider, but not necessarily abandon, their positions as new information becomes available. The results of one or more steps of the dispute resolution process may persuade the surrogate that the requested treatments are indeed inappropriate. Similarly, sometimes the process persuades clinicians that the requested treatments are not outside the boundaries of acceptable practice. It is therefore important to ensure ongoing communication so that negotiated agreements can be reached when possible, rather than decisions imposed unwillingly on one party by the other.",
"     </li>",
"     <li>",
"      Attempt to transfer the patient to a willing provider &ndash; If an agreement cannot be reached, the clinician should offer the surrogate the opportunity to transfer the patient to a willing provider. This step is important because, with the exception of treatments that are futile, there is often uncertainty about what are boundaries of acceptable practice in patients with advanced critical illness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Clinicians and the institution should offer to share responsibility for seeking an alternative provider because genuine efforts to facilitate transfer require expertise that patients and families generally do not have. This includes identifying and contacting alternative providers, explaining the clinical situation to other clinicians, and assisting with the logistics of the transfer process.",
"     </li>",
"     <li>",
"      If no willing provider can be found after a diligent search, this creates a stronger case that the requested treatments are outside the boundaries of acceptable medical practice. If a willing provider is found, the patient should be transferred or, alternatively, the treating clinicians should reconsider their position that the requested treatments are inappropriate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inform the surrogate of their right to seek legal intervention &ndash; Although case review by a multidisciplinary hospital committee accomplishes the goal of gaining the perspective of individuals not directly involved in the patient&rsquo;s care, some have argued that this review may yield a biased conclusion because the membership on such hospital committees tends to be dominated by employees of the hospital [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/20\">",
"       20",
"      </a>",
"      ]. Because a central element of procedural fairness is preserving the opportunity for appeal of the decision to a legitimate, impartial body, it is our opinion that patients or their surrogates should be informed of their right to seek legal intervention to compel clinicians to provide the requested treatments. Although in the United States this role has traditionally been filled by the courts, other appeals processes are theoretically possible, such as non-judicial appeals boards [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/21\">",
"       21",
"      </a>",
"      ] or mechanisms similar to the Ontario Capacity and Consent Board [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Withhold or withdraw the disputed treatments &ndash; If the hospital review committee concurs with the clinicians&rsquo; judgment, no willing provider can be located, and the family chooses not to seek legal intervention, clinicians are ethically justified to refuse to provide the requested treatments. Outside of the state of Texas [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/23\">",
"       23",
"      </a>",
"      ], this procedural approach does not guarantee a legal safe harbor for clinicians. Therefore, it is important that hospital leadership in which the patient is being cared for supports the clinicians. As an example, the policy at Children&rsquo;s Hospital in Boston labels decisions to refuse to provide requested treatments that emerge from a similar process as institutional decisions, rather than only decisions by individual providers [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24934/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034269\">",
"    <span class=\"h1\">",
"     TIME PRESSURED DECISIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally there will be situations in which surrogates request treatments that clinicians deem inappropriate and, because of the urgency of the clinical situation, there is not sufficient time to undertake the six step resolution process outlined above. Whenever possible, a temporizing treatment plan should be initiated to allow the dispute resolution process to be completed.",
"   </p>",
"   <p>",
"    Sometimes no such temporizing strategy is feasible and the treating clinicians have a very high degree of certainty that the requested treatments are outside the boundaries of accepted practice. As an example, sometimes a surrogate insists on ongoing cardiopulmonary resuscitation (CPR) even after the clinical team has performed multiple unsuccessful rounds of CPR and the clinical team believes that further resuscitative efforts would be inappropriate. If the clinicians continued CPR, they would be violating their best understanding of their professional duties. In such circumstances, we recommend that clinicians ensure that there is consensus among the clinicians present, explain the reasons for stopping to the surrogate, and then stop resuscitative efforts.",
"   </p>",
"   <p>",
"    The ethically important features of this strategy are (1) that the clinicians base their judgments on their best understanding of their professional obligations and (2) only enact this unilateral strategy when there is no opportunity for a temporizing strategy and there is a high degree of certainty that what is being requested is outside the boundaries of accepted practice. Such unilateral decisions come with a degree of legal uncertainty. Moreover, unilateral decisions in the face of conflict will likely cause substantial distress for surrogates. Therefore, we recommend that psychological support services be offered to them and that retrospective review of such cases be conducted by the hospital ethics committee with the clinical team. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5034276\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term &ldquo;futile treatment&rdquo; should only be used to describe interventions that cannot accomplish the patient&rsquo;s medical goals, as determined through careful discussions with the patient&rsquo;s surrogates. (See",
"      <a class=\"local\" href=\"#H5034234\">",
"       'Definitions of futile and potentially inappropriate treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The term &ldquo;potentially inappropriate&rdquo; should be used to describe requested treatments that clinicians believe go against their best understanding of their professional obligations, such as treatments that are exceedingly unlikely to accomplish the patient&rsquo;s goals, are an unfair allocation of scarce resources, or that are intended to achieve a goal that is contrary to the clinician&rsquo;s professional integrity. (See",
"      <a class=\"local\" href=\"#H5034234\">",
"       'Definitions of futile and potentially inappropriate treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinicians need not provide futile treatments, but should carefully explain their reasoning to surrogates and attempt to persuade the surrogates prior to unilateral refusal. (See",
"      <a class=\"local\" href=\"#H5034248\">",
"       'Responding to requests for futile treatments'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A clinician&rsquo;s initial response to a request for potentially inappropriate treatment should include intensive efforts to find a negotiated agreement, through both dialogue with the family and the involvement of communication experts such as hospital ethics committees, palliative care consultants, or mediation experts. If a mutually acceptable treatment plan cannot be found, there should be a fair process of dispute resolution. (See",
"      <a class=\"local\" href=\"#H5034255\">",
"       'Responding to requests for potentially inappropriate treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend the following steps as part of a fair process of dispute resolution: (1) Inform the surrogate about the dispute resolution process, (2) request review by a multidisciplinary hospital committee, (3) continue dialogue between the clinical team and surrogate, (4) attempt to transfer the patient to a willing provider, (5) inform surrogates of their right to seek legal intervention, and (6) if the hospital review committee concurs with the clinicians&rsquo; judgment, no willing alternative provider can be located, and the family chooses not to seek legal intervention, clinicians are ethically justified to refuse to provide the requested treatments. (See",
"      <a class=\"local\" href=\"#H5034262\">",
"       'Recommended approach to dispute resolution'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/1\">",
"      Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments. Crit Care Med 1997; 25:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/2\">",
"      Curtis JR, Vincent JL. Ethics and end-of-life care for adults in the intensive care unit. Lancet 2010; 376:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/3\">",
"      Fair allocation of intensive care unit resources. American Thoracic Society. Am J Respir Crit Care Med 1997; 156:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/4\">",
"      Emanuel EJ. A communal vision of care for incompetent patients. Hastings Cent Rep 1987; 17:15.",
"     </a>",
"    </li>",
"    <li>",
"     Rawls J. Political liberalism; expanded edition, Columbia University Press, New York, NY 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/6\">",
"      Piers RD, Azoulay E, Ricou B, et al. Perceptions of appropriateness of care among European and Israeli intensive care unit nurses and physicians. JAMA 2011; 306:2694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/7\">",
"      Azoulay E, Pochard F, Kentish-Barnes N, et al. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med 2005; 171:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/8\">",
"      Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in the intensive care unit: a consensus statement by the American College [corrected] of Critical Care Medicine. Crit Care Med 2008; 36:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/9\">",
"      Prendergast TJ. Resolving conflicts surrounding end-of-life care. New Horiz 1997; 5:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/10\">",
"      Garros D, Rosychuk RJ, Cox PN. Circumstances surrounding end of life in a pediatric intensive care unit. Pediatrics 2003; 112:e371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/11\">",
"      Campbell ML, Guzman JA. Impact of a proactive approach to improve end-of-life care in a medical ICU. Chest 2003; 123:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/12\">",
"      Campbell ML, Guzman JA. A proactive approach to improve end-of-life care in a medical intensive care unit for patients with terminal dementia. Crit Care Med 2004; 32:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/13\">",
"      Norton SA, Hogan LA, Holloway RG, et al. Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med 2007; 35:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/14\">",
"      Kaufer M, Murphy P, Barker K, Mosenthal A. Family satisfaction following the death of a loved one in an inner city MICU. Am J Hosp Palliat Care 2008; 25:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/15\">",
"      Schneiderman LJ, Gilmer T, Teetzel HD, et al. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 2003; 290:1166.",
"     </a>",
"    </li>",
"    <li>",
"     American Medical Association Council on Ethical and Judicial Affairs. Opinion 2.20 - withholding or withdrawing life-sustaining medical treatment, 1996. file://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion220.page (Accessed on April 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/17\">",
"      Luce JM. A history of resolving conflicts over end-of-life care in intensive care units in the United States. Crit Care Med 2010; 38:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/18\">",
"      Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs. JAMA 1999; 281:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/19\">",
"      Daniels N, Sabin J. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff 1997; 26:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/20\">",
"      Burns JP, Truog RD. Futility: a concept in evolution. Chest 2007; 132:1987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/21\">",
"      Spielman B. Collective decisions about medical futility. J Law Med Ethics 1994; 22:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/22\">",
"      Sibbald RW, Chidwick P. Best interests at end of life: a review of decisions made by the Consent and Capacity Board of Ontario. J Crit Care 2010; 25:171.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/23\">",
"      Fine RL, Mayo TW. Resolution of futility by due process: early experience with the Texas Advance Directives Act. Ann Intern Med 2003; 138:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24934/abstract/24\">",
"      Truog RD. Counterpoint: The Texas advance directives act is ethically flawed: medical futility disputes must be resolved by a fair process. Chest 2009; 136:968.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16296 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-67DC1C7482-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24934=[""].join("\n");
var outline_f24_22_24934=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5034276\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034227\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034234\">",
"      DEFINITIONS OF FUTILE AND POTENTIALLY INAPPROPRIATE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034241\">",
"      PREVENTING INTRACTABLE CONFLICTS ABOUT FUTILE OR POTENTIALLY INAPPROPRIATE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034248\">",
"      RESPONDING TO REQUESTS FOR FUTILE TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034255\">",
"      RESPONDING TO REQUESTS FOR POTENTIALLY INAPPROPRIATE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5034262\">",
"      Recommended approach to dispute resolution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034269\">",
"      TIME PRESSURED DECISIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5034276\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PALC/16296\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PALC/16296|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?28/35/29246\" title=\"algorithm 1\">",
"      Goals of therapy in ICU",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/40/12938?source=related_link\">",
"      Communication in the ICU: Holding a family meeting",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_22_24935="Trichoschisis";
var content_f24_22_24935=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87475&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Trichoschisis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse fractures are evident in several hair shafts in this hair specimen from a patient with trichothiodystrophy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24935=[""].join("\n");
var outline_f24_22_24935=null;
var title_f24_22_24936="Overview of procedural sedation for gastrointestinal endoscopy";
var content_f24_22_24936=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of procedural sedation for gastrointestinal endoscopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24936/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24936/contributors\">",
"     Jonathan Cohen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24936/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24936/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24936/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24936/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/22/24936/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of gastrointestinal endoscopy has greatly expanded the diagnostic and therapeutic capabilities of gastroenterologists. Adequate patient tolerance is essential for successful completion of a safe examination and compliance with subsequent follow-up. As a result, endoscopists have developed skills in administering a variety of sedative and analgesic agents to facilitate procedures and enhance patient comfort.",
"   </p>",
"   <p>",
"    This topic review will focus on standard methods of procedural sedation. Complications related to sedation, issues related to endoscopic procedures without sedation, and the management of patients who are difficult to sedate are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=see_link\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREPROCEDURE PREPARATION AND ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients undergoing gastrointestinal endoscopy should be assessed with a history and physical examination prior to administering sedation to identify factors that increase the risk of an adverse outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The history should determine if any of the following are present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Significant cardiac or pulmonary disease",
"     </li>",
"     <li>",
"      Sleep apnea or snoring",
"     </li>",
"     <li>",
"      History of a difficult intubation",
"     </li>",
"     <li>",
"      Seizure or other neurologic disorder",
"     </li>",
"     <li>",
"      A prior adverse reaction to sedation or anesthesia",
"     </li>",
"     <li>",
"      Current medications",
"     </li>",
"     <li>",
"      Drug or food allergies",
"     </li>",
"     <li>",
"      Alcohol or other substance abuse",
"     </li>",
"     <li>",
"      Recent food ingestion within the past six hours or clear liquid ingestion within the past two hours",
"     </li>",
"     <li>",
"      Significant nausea and vomiting, suggesting possibility of aspiration risk",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The physical examination should include assessment of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Baseline level of consciousness",
"     </li>",
"     <li>",
"      Vital signs and weight",
"     </li>",
"     <li>",
"      Heart and lung auscultation",
"     </li>",
"     <li>",
"      Airway assessment",
"     </li>",
"     <li>",
"      Presence of obesity",
"     </li>",
"     <li>",
"      Presence of ascites, ileus, or abdominal distension, which potentially increase the risk of aspiration due to a full stomach",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The airway examination should include determination of the patient's Mallampati classification, which is used to identify patients at increased risk of difficult intubation (",
"    <a class=\"graphic graphic_figure graphicRef75229 \" href=\"UTD.htm?2/36/2626\">",
"     figure 1",
"    </a>",
"    ). Other physical features that could make positive-pressure ventilation or intubation difficult include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obesity",
"     </li>",
"     <li>",
"      A short, thick neck",
"     </li>",
"     <li>",
"      Cervical spine disease",
"     </li>",
"     <li>",
"      Structural abnormalities of the mouth, jaw, or oral cavity",
"     </li>",
"     <li>",
"      A decreased hyoid-mental distance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No data have been published showing that determining the Mallampati classification prior to endoscopy leads to reduced cardiopulmonary complications. Despite this fact, we feel it is advisable to identify in advance those patients who would be at increased risk for difficult airway management should they cross into deeper levels of sedation in which airway reflexes might be lost, requiring intervention. Such information can affect the setting in which the endoscopy is performed (hospital versus outpatient center), which sedatives are chosen, and whether to employ the help of an anesthesiologist or a certified registered nurse anesthetist.",
"   </p>",
"   <p>",
"    Once the history and physical examination are complete, patients should be classified using the American Society for Anesthesiology (ASA) physical status classification to quantify their overall comorbid disease risk (",
"    <a class=\"graphic graphic_table graphicRef56098 \" href=\"UTD.htm?8/33/8733\">",
"     table 1",
"    </a>",
"    ). The ASA score should be documented in the endoscopy report. Consultation with an anesthesiologist may be considered if any of the following are present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      ASA classification of III (all patients who are ASA class IV or V require evaluation by an anesthesiologist)",
"     </li>",
"     <li>",
"      Mallampati classification of III or IV (",
"      <a class=\"graphic graphic_figure graphicRef75229 \" href=\"UTD.htm?2/36/2626\">",
"       figure 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      History of an adverse reaction to sedation",
"     </li>",
"     <li>",
"      History of inadequate sedation with standard medication doses",
"     </li>",
"     <li>",
"      History of difficult intubation",
"     </li>",
"     <li>",
"      Alcohol or substance abuse",
"     </li>",
"     <li>",
"      Sleep apnea",
"     </li>",
"     <li>",
"      Need for emergency endoscopy",
"     </li>",
"     <li>",
"      If the planned procedure is likely to be complex or prolonged",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women of child-bearing age should be asked if they could be pregnant. If any doubt exists, a pregnancy test should be obtained prior to administering sedation. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Pregnancy and lactation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Recommendations differ with regard to preprocedure fasting for elective procedures. The ASA guidelines state that patients should fast a minimum of two hours following clear liquid ingestion and six hours for a light meal prior to a procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/1\">",
"     1",
"    </a>",
"    ]. In contrast, the American College of Emergency Physicians states \"recent food intake is not a contraindication for administering procedural sedation and analgesia, but should be considered in choosing the timing and target level of sedation\" [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/2\">",
"     2",
"    </a>",
"    ]. Our practice is to follow the ASA approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LEVELS OF SEDATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The levels of sedation are defined as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minimal sedation (anxiolysis) refers to a drug-induced state during which patients respond normally to verbal commands. Cognitive function and coordination may be impaired, but ventilatory and cardiovascular functions are unaffected.",
"     </li>",
"     <li>",
"      Moderate sedation (conscious sedation) refers to drug-induced depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation. No interventions are required to maintain a patent airway, and spontaneous ventilation is adequate. Cardiovascular function is usually maintained.",
"     </li>",
"     <li>",
"      Deep sedation refers to drug-induced depression of consciousness during which patients cannot be easily aroused, but respond purposefully following repeated or painful stimulation. The ability to independently maintain ventilatory function may be impaired. Patients may require assistance in maintaining a patent airway, and spontaneous ventilation may be inadequate. Cardiovascular function is usually maintained.",
"     </li>",
"     <li>",
"      General anesthesia refers to a drug-induced loss of consciousness during which patients are not arousable, even by painful stimulation. The ability to independently maintain ventilatory function is often impaired. Such patients often require assistance in maintaining a patent airway, and positive pressure ventilation may be required because of depressed spontaneous ventilation or drug-induced depression of neuromuscular function. Cardiovascular function may be impaired.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The infrequent but potentially severe cardiopulmonary complications of procedural sedation require careful patient monitoring. This includes monitoring of blood pressure, pulse oximetry, and, in patients with cardiovascular disease, electrocardiography. Monitoring also requires observation of the patient throughout the procedure to watch for reduced ventilatory effort and secretions, which might result in aspiration.",
"   </p>",
"   <p>",
"    Endoscopy training should include instruction on proper administration of sedation and appropriate patient monitoring. Full oxygen tanks, oral suction devices, oral airways, and reversal agents must be readily available in the endoscopy unit and resuscitation equipment must be easily accessible. Endoscopy personnel must be adequately trained to resuscitate patients receiving procedural sedation. Finally, equipment must be regularly inspected and staff kept fully updated in their ability to use it.",
"   </p>",
"   <p>",
"    Patient monitoring during sedation is accomplished by a combination of visual assessment and monitoring devices. Sedation is graded along a continuum, from minimal sedation to general anesthesia. Moderate sedation is appropriate for most endoscopic procedures. However, it is not always possible to predict how a patient will respond to sedation, and some patients move past moderate sedation into deep sedation. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Levels of sedation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Methods for patient monitoring include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemodynamic monitoring &ndash; Heart rate and blood pressure should be monitored in all patients receiving intravenous sedation. The heart rate should be monitored continuously and the blood pressure should be checked at baseline and then at three to five minute intervals.",
"     </li>",
"     <li>",
"      Electrocardiography &ndash; The American Society for Anesthesiology (ASA) guidelines recommend continuous electrocardiography for patients with significant cardiovascular disease or dysrhythmias [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/1\">",
"       1",
"      </a>",
"      ]. Electrocardiography is not required for low-risk patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/3\">",
"       3",
"      </a>",
"      ]. Low-risk patients include those who are ASA class 1 or class 2 (",
"      <a class=\"graphic graphic_table graphicRef56098 \" href=\"UTD.htm?8/33/8733\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Pulse oximetry &ndash; Continuous pulse oximetry is recommended for all patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/3\">",
"       3",
"      </a>",
"      ]. However, it is relatively insensitive for detecting early hypoventilation and is not a replacement for direct observation of the patient.",
"     </li>",
"     <li>",
"      Capnography &ndash; Capnography (carbon dioxide monitoring in exhaled breath) is a noninvasive technique that is more sensitive than direct visual observation or pulse oximetry for detecting hypoventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/4-7\">",
"       4-7",
"      </a>",
"      ]. The ASA recommends that capnography be considered for patients receiving deep sedation and for patients whose ventilation cannot be observed directly during moderate sedation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/1\">",
"       1",
"      </a>",
"      ]. It is not yet recommended for routine use during endoscopy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The capnography probe typically consists of a nasal cannula, and possibly an additional probe to sample gas from the mouth. An infrared measuring cell analyzes the carbon dioxide content of inspired and expired gases. The data is displayed as a capnographic waveform (or capnogram). In a normal waveform, there is a peak during expiration and a trough during inspiration. By analyzing the waveform, patterns of respiration can be identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transcutaneous capnometry to measure carbon dioxide has also been used. Capnometry differs from capnography in that, while it provides a measurement of carbon dioxide, it does not display the measurement as a waveform. A controlled trial evaluating this approach in 195 patients undergoing ERCP found that hypercapnia was not reliably detected in patients receiving supplemental oxygen by clinical observation or pulse oximetry [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/8\">",
"     8",
"    </a>",
"    ]. The addition of transcutaneous carbon dioxide monitoring prevented severe carbon dioxide retention more effectively than intensive clinical monitoring and pulse oximetry alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SUPPLEMENTAL OXYGEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal oxygen supplementation readily reverses or prevents oxygen desaturation during endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] and is recommended for patients receiving sedation by both the American Society for Anesthesiology and the American Society of Gastrointestinal Endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/1,9-11\">",
"     1,9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of nasal oxygen was demonstrated in a randomized trial in which 289 patients were assigned to receive either no oxygen or oxygen via a nasal cannula at a rate of 3",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/12\">",
"     12",
"    </a>",
"    ]. A reduction in the proportion of patients with oxygen desaturations was observed in the group assigned to supplemental oxygen compared to those who did not receive supplemental oxygen for upper endoscopy, colonoscopy, and endoscopic retrograde cholangiopancreatography (0 versus 28 percent, 6 versus 37 percent, and 0 versus 50 percent, respectively).",
"   </p>",
"   <p>",
"    Prevention of oxygen desaturation may be particularly important in patients with a history of coronary heart disease. In such patients, supplemental oxygen can significantly reduce the rate of ST-segment changes (both ST-segment elevations and depressions) on the electrocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link&amp;anchor=H5#H5\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\", section on 'Cardiopulmonary complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SEDATIVES AND ANALGESICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of agents have been used to achieve a state of deep relaxation and analgesia. This section will focus on the medications currently in widespread use (",
"    <a class=\"graphic graphic_table graphicRef65736 \" href=\"UTD.htm?32/6/32877\">",
"     table 2",
"    </a>",
"    ). The most common approach to sedation for endoscopy is intravenous conscious sedation, which involves the administration of benzodiazepines alone or in combination with opiates to achieve moderate levels of sedation. A systematic review of 36 studies involving procedural sedation found that moderate sedation provides a high level of clinician and patient satisfaction and a low risk of serious adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Levels of sedation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A number of other approaches to procedural sedation continue to be studied (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    and patient controlled sedation and analgesia), but are not used routinely [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=see_link&amp;anchor=H10#H10\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\", section on 'Patient-controlled analgesia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Choice of medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choosing the right medications and doses depends upon an assessment of the individual patient and the degree of sedation required to adequately complete the intended procedure. The level of sedation required varies with patient characteristics and the procedure. However, for a majority of patients, the combination of an intravenous benzodiazepine and an opioid is adequate. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Levels of sedation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Patient-related considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a number of clinical trials, the following patient characteristics were associated with tolerance of upper endoscopy or colonoscopy with little or no sedation (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Older age",
"     </li>",
"     <li>",
"      Male sex",
"     </li>",
"     <li>",
"      Absence of anxiety",
"     </li>",
"     <li>",
"      Absence of an abdominal pain history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The factors that predict poor procedural tolerance are less well studied. Factors that have been identified include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A history of prior difficulty with procedural sedation",
"     </li>",
"     <li>",
"      Benzodiazepine or opioid use (prescribed or illicit)",
"     </li>",
"     <li>",
"      Heavy alcohol use",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Up to 30 percent of patients with these risk factors will have difficulty achieving adequate sedation. Another problem is that some patients develop paradoxical agitation in response to benzodiazepines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=see_link\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Comorbid illnesses and current medications should be considered when deciding upon the sedation regimen. It is especially important to identify potential drug interactions or conditions that may affect drug metabolism or excretion.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    , for example, interacts with monoamine oxidase inhibitors. In addition, because it has active metabolites, meperidine may cause problems in patients with advanced liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Procedure-related considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A second major factor that determines the type of procedural sedation used is the degree of difficulty and the level of sedation required for a particular procedure. There are data suggesting that elective upper endoscopy, sigmoidoscopy, and in some cases, colonoscopy require little or no sedation for the typical patient. However, in the United States, most gastroenterologists give some intravenous procedural sedation for all procedures except flexible sigmoidoscopy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Emergency therapeutic procedures and endoscopic retrograde cholangiopancreatography (ERCP) are frequently longer procedures and may require deeper levels of sedation. This is particularly important with maneuvers such as sphincterotomy or application of electrocautery to a visible vessel, where small patient position changes may have significant adverse effects. Thus, patients undergoing these procedures may require deeper sedation and consultation with an anesthesiologist should be considered. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Preprocedure preparation and assessment'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pharyngeal anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharyngeal anesthesia is typically used to suppress the gag reflex during procedures involving the upper gastrointestinal tract. Commonly used topical anesthetics include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/7/6264?source=see_link\">",
"     benzocaine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/12/36032?source=see_link\">",
"     tetracaine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , which are administered by aerosol spray or gargling. The effects last for up to one hour.",
"   </p>",
"   <p>",
"    The efficacy of pharyngeal anesthesia was best evaluated in a meta-analysis of five randomized controlled trials with a total of 491 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/24\">",
"     24",
"    </a>",
"    ]. The patients who received pharyngeal anesthesia were significantly more likely to report \"no\" or \"minimal discomfort\" (odds ratio 1.9) and endoscopists were significantly more likely in such patients to rate the procedure as \"not difficult\" (odds ratio 2.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pharyngeal anesthesia may be particularly helpful in patients who elect to receive little or no intravenous sedation and in those who report gagging easily. On the other hand, pharyngeal anesthesia can likely be omitted for most patients receiving the doses of intravenous sedation typically used in the United States.",
"   </p>",
"   <p>",
"    Topical anesthetics have been associated with methemoglobinemia and should be",
"    <strong>",
"     avoided",
"    </strong>",
"    in patients with a previous history of methemoglobinemia or known glucose-6-phosphate dehydrogenase (G6PD) deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Intravenous agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benzodiazepines and opiates are usually used in combination to take advantage of their synergistic effects, especially for longer procedures. However, such combinations may increase the risk of oxygen desaturation and cardiorespiratory complications. In addition, these agents should be used with caution in elderly patients and in patients with significant liver or kidney disease, as they may be more sensitive to their sedative and cardiopulmonary effects.",
"   </p>",
"   <p>",
"    If benzodiazepines and opiates are used in combination and additional doses are required during the procedure, it is important to give only one drug at a time for subsequent boluses, waiting a few minutes following each dose to observe the effect before considering additional medication. In particular, care must be taken in elderly patients, because a prolonged circulation time may delay their response to medication administration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Benzodiazepines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benzodiazepines are used for their sedative, amnestic, and anxiolytic properties. The two most commonly used benzodiazepines are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65736 \" href=\"UTD.htm?32/6/32877\">",
"     table 2",
"    </a>",
"    ). Most endoscopists favor midazolam because of its fast onset of action, short duration of action, and high amnestic properties. The efficacy of sedation using these two benzodiazepines is comparable, taking differences in potency into account.",
"   </p>",
"   <p>",
"    With respect to potency,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    was 3.4 times more potent than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/25\">",
"     25",
"    </a>",
"    ]. The difference in potency begins to increase in patients over age 60 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In patients over age 70, the midazolam dose necessary for appropriate sedation is often so low that overdosing can easily occur and may account for some cardiopulmonary deaths that have been reported in elderly patients who received intravenous midazolam [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/27\">",
"     27",
"    </a>",
"    ]. On the other hand, the longer half-life of diazepam may be a concern in cognitively impaired or elderly patients.",
"   </p>",
"   <p>",
"    The usual initial dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    is 1 to 2 mg in younger healthy patients given along with an opioid. If the initial dose does not produce adequate sedation, additional 0.5 to 1 mg boluses can be given every two to three minutes. For elderly patients and patients with significant liver or renal disease, we suggest reducing both the initial bolus dose of midazolam and the subsequent doses (0.5 to 1 mg initial bolus and 0.25 to 0.5 mg subsequent doses). In these patients it may also be reasonable to use a benzodiazepine as a single agent, omitting the opioid from the regimen.",
"   </p>",
"   <p>",
"    When necessary, the effects of benzodiazepines can be temporarily reversed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/6/41062?source=see_link\">",
"     flumazenil",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link&amp;anchor=H9#H9\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\", section on 'Reversal agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Opiates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opiates have both sedative and analgesic properties. The two most commonly used are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_table graphicRef65736 \" href=\"UTD.htm?32/6/32877\">",
"     table 2",
"    </a>",
"    ). Opiates must be given cautiously in patients taking other central nervous system depressants, such as other opiates, sedatives, tranquilizers, phenothiazines, or antihistamines. As with benzodiazepines, the opioid dose should be reduced in elderly patients and patients with significant liver or kidney disease. In addition, opiates should be used cautiously in patients with a history of seizures, since opiates lower the seizure threshold.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     Fentanyl",
"    </a>",
"    is favored by anesthesiologists because of its rapid onset of action and clearance and reduced incidence of nausea compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    . A randomized controlled trial comparing fentanyl with meperidine in 111 adults undergoing upper endoscopy or colonoscopy found significantly shorter procedure times with fentanyl, mainly related to reduced recovery time [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     Meperidine",
"    </a>",
"    should be avoided in patients taking monoamine oxidase (MAO) inhibitors due to drug interactions.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     Morphine",
"    </a>",
"    is another option, but is often avoided due to its slow onset (",
"    <a class=\"graphic graphic_table graphicRef65736 \" href=\"UTD.htm?32/6/32877\">",
"     table 2",
"    </a>",
"    ) and because of concern about stimulating smooth muscle contraction and inducing spasm of the sphincter of Oddi, which may be a particular problem during endoscopic retrograde cholangiopancreatography.",
"   </p>",
"   <p>",
"    Opiates can be temporarily reversed with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    , though its use can induce acute narcotic withdrawal in patients with a history of chronic opioid use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link&amp;anchor=H9#H9\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\", section on 'Reversal agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Propofol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    acts by increasing gamma amino butyric acid (GABA) activity in the brain. Its benefits include rapid onset of action, rapid clearance, and reversibility of effect once the drip is shut off. It has some antiemetic effect and has a weaker amnestic effect than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    , but no analgesic effect. The major drawback of propofol is that it can cause respiratory depression.",
"   </p>",
"   <p>",
"    The role of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    for routine endoscopic procedures is controversial and discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=see_link\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREGNANCY AND LACTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety and efficacy of endoscopic procedures during pregnancy have not been extensively studied. Our approach is to follow the recommendations from a 2012 guideline issued by the American Society for Gastrointestinal Endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/29\">",
"     29",
"    </a>",
"    ]. Its major conclusions with regard to procedural sedation are summarized here:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopy during pregnancy should only be performed if there is a strong indication, and when possible, it should be postponed until the second trimester.",
"     </li>",
"     <li>",
"      Close involvement of the obstetrical staff is recommended.",
"     </li>",
"     <li>",
"      The degree of maternal and fetal monitoring needs to be individualized.",
"     </li>",
"     <li>",
"      For procedural sedation during pregnancy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      (category B) alone is preferred, followed by small doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      (category D) as needed. If deep sedation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      (category B) is needed, it should be administered by an anesthesia provider.",
"     </li>",
"     <li>",
"      For procedural sedation in women who are breastfeeding:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"       Fentanyl",
"      </a>",
"      is preferred to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      because the concentrations of fentanyl in breast milk are too low to be pharmacologically significant, as opposed to meperidine which is concentrated in breast milk. Breastfeeding may be continued without interruption after maternal fentanyl administration.",
"     </li>",
"     <li>",
"      Infants should",
"      <strong>",
"       not",
"      </strong>",
"      be breastfed for at least four hours after maternal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      administration. After four hours, breast milk should be pumped and discarded before reinitiating breastfeeding.",
"     </li>",
"     <li>",
"      Breast feeding may be continued in women who have received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      because the amount of the drug excreted in breast milk is small (0.015 percent of the maternal dose). This represents a change from the prior recommendation (previously it was recommended that infants not be breastfed for four hours).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Procedural sedation for gastrointestinal endoscopy is generally well tolerated, but complications can occur. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     POST-PROCEDURE MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients remain at risk for cardiopulmonary complications of sedation after the procedure is completed. At this time, the absence of stimulation related to the procedure and the presence of active drug and metabolites in the circulation create an increased risk of respiratory depression. As a result, vital signs, respiratory effort, and level of consciousness need to be monitored at regular intervals.",
"   </p>",
"   <p>",
"    In addition, many immediate complications of endoscopy become evident during the recovery period as the analgesics wear off and the level of consciousness improves. Particular attention is required in individuals who have received reversal agents for respiratory depression or other signs of resedation, since the duration of action of the reversal agents may be shorter than that of the sedatives (",
"    <a class=\"graphic graphic_table graphicRef65736 \" href=\"UTD.htm?32/6/32877\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=see_link&amp;anchor=H9#H9\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\", section on 'Reversal agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Scoring systems have been developed to guide the timing of patient discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. One such system is the Aldrete scoring system [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24936/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Respiration",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Able to take deep breath and cough &ndash; 2 points",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Dyspnea/shallow",
"      </span>",
"      breathing &ndash; 1 point",
"     </li>",
"     <li>",
"      Apnea &ndash; 0 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oxygen saturation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      &gt;95 percent on room air &ndash; 2 points",
"     </li>",
"     <li>",
"      90 to 95 percent on room air &ndash; 1 point",
"     </li>",
"     <li>",
"      &lt;90 percent &ndash; 0 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Consciousness",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Full awake &ndash; 2 points",
"     </li>",
"     <li>",
"      Arousable on calling &ndash; 1 point",
"     </li>",
"     <li>",
"      Not responding &ndash; 0 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood pressure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Within 20 mmHg of baseline &ndash; 2 points",
"     </li>",
"     <li>",
"      Within 20 to 50 mmHg of baseline &ndash; 1 point",
"     </li>",
"     <li>",
"      Within 50 mmHg of baseline &ndash; 0 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Able to move four extremities &ndash; 2 points",
"     </li>",
"     <li>",
"      Able to move two extremities &ndash; 1 point",
"     </li>",
"     <li>",
"      Able to move zero extremities &ndash; 0 points",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An Aldrete score of 9 or greater is suggested for discharge. In general, patients should be able to tolerate some oral intake and have sufficient return of motor skills to walk and dress themselves prior to discharge.",
"   </p>",
"   <p>",
"    Outpatients should be discharged with an adult to accompany them home and strongly advised not to drive a car or operate machinery for at least six hours. Important instructions should be written down, since the amnestic effects of benzodiazepines may not have dissipated when verbal instructions are given.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/11/18611?source=see_link\">",
"       \"Patient information: Colonoscopy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/30/9698?source=see_link\">",
"       \"Patient information: Colonoscopy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All patients should be assessed with a history and physical examination prior to administering sedation to identify factors that could put them at increased risk for an adverse outcome. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preprocedure preparation and assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that an anesthesiologist be consulted for patients who are at increased risk of complications related to sedation, who are likely to be difficult to sedate, who are considered high-risk for aspiration, or who are undergoing complex endoscopic procedures. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preprocedure preparation and assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women of child-bearing age should be asked if they could be pregnant. If any doubt exists, a pregnancy test should be obtained prior to administering sedation.",
"     </li>",
"     <li>",
"      For a majority of patients, adequate sedation can be achieved with the combination of an intravenous benzodiazepine and an opioid. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Sedatives and analgesics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The doses of sedatives administered may need to be decreased in elderly patients and in patients with significant liver or kidney disease. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Sedatives and analgesics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The infrequent but potentially severe cardiopulmonary complications of procedural sedation require careful patient monitoring. This includes monitoring of blood pressure, pulse oximetry, and electrocardiography (in patients with cardiovascular disease). It also requires observation of the patient throughout the procedure to watch for reduced ventilatory effort and secretions, which might result in aspiration. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients require continued monitoring following their procedures. Scoring systems have been developed to guide the timing of patient discharge. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Post-procedure monitoring'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/1\">",
"      Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 441: Oral intake during labor. Obstet Gynecol 2009; 114:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/2\">",
"      Godwin SA, Caro DA, Wolf SJ, et al. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med 2005; 45:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/3\">",
"      Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/4\">",
"      Poirier MP, Gonzalez Del-Rey JA, McAneney CM, DiGiulio GA. Utility of monitoring capnography, pulse oximetry, and vital signs in the detection of airway mishaps: a hyperoxemic animal model. Am J Emerg Med 1998; 16:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/5\">",
"      Vargo JJ, Zuccaro G Jr, Dumot JA, et al. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc 2002; 55:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/6\">",
"      Lightdale JR, Goldmann DA, Feldman HA, et al. Microstream capnography improves patient monitoring during moderate sedation: a randomized, controlled trial. Pediatrics 2006; 117:e1170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/7\">",
"      Beitz A, Riphaus A, Meining A, et al. Capnographic monitoring reduces the incidence of arterial oxygen desaturation and hypoxemia during propofol sedation for colonoscopy: a randomized, controlled study (ColoCap Study). Am J Gastroenterol 2012; 107:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/8\">",
"      Nelson DB, Freeman ML, Silvis SE, et al. A randomized, controlled trial of transcutaneous carbon dioxide monitoring during ERCP. Gastrointest Endosc 2000; 51:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/9\">",
"      Gross JB, Long WB. Nasal oxygen alleviates hypoxemia in colonoscopy patients sedated with midazolam and meperidine. Gastrointest Endosc 1990; 36:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/10\">",
"      Wang CY, Ling LC, Cardosa MS, et al. Hypoxia during upper gastrointestinal endoscopy with and without sedation and the effect of pre-oxygenation on oxygen saturation. Anaesthesia 2000; 55:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/11\">",
"      Waring JP, Baron TH, Hirota WK, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003; 58:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/12\">",
"      Reshef R, Shiller M, Kinberg R, et al. A prospective study evaluating the usefulness of continuous supplemental oxygen in various endoscopic procedures. Isr J Med Sci 1996; 32:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/13\">",
"      Jurell KR, O'Connor KW, Slack J, et al. Effect of supplemental oxygen on cardiopulmonary changes during gastrointestinal endoscopy. Gastrointest Endosc 1994; 40:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/14\">",
"      McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc 2008; 67:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/15\">",
"      Forbes GM, Collins BJ. Nitrous oxide for colonoscopy: a randomized controlled study. Gastrointest Endosc 2000; 51:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/16\">",
"      Stermer E, Gaitini L, Yudashkin M, et al. Patient-controlled analgesia for conscious sedation during colonoscopy: a randomized controlled study. Gastrointest Endosc 2000; 51:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/17\">",
"      Aboumarzouk OM, Agarwal T, Syed Nong Chek SA, et al. Nitrous oxide for colonoscopy. Cochrane Database Syst Rev 2011; :CD008506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/18\">",
"      Etzkorn KP, Diab F, Brown RD, et al. Endoscopic retrograde cholangiopancreatography under general anesthesia: indications and results. Gastrointest Endosc 1998; 47:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/19\">",
"      Wilcox CM, Forsmark CE, Cello JP. Utility of droperidol for conscious sedation in gastrointestinal endoscopic procedures. Gastrointest Endosc 1990; 36:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/20\">",
"      Cohen J, Haber GB, Dorais JA, et al. A randomized, double-blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc 2000; 51:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/21\">",
"      Yimcharoen P, Fogel EL, Kovacs RJ, et al. Droperidol, when used for sedation during ERCP, may prolong the QT interval. Gastrointest Endosc 2006; 63:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/22\">",
"      Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol 2002; 97:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/23\">",
"      Assy N, Rosser BG, Grahame GR, Minuk GY. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 1999; 49:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/24\">",
"      Evans LT, Saberi S, Kim HM, et al. Pharyngeal anesthesia during sedated EGDs: is \"the spray\" beneficial? A meta-analysis and systematic review. Gastrointest Endosc 2006; 63:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/25\">",
"      Zakko SF, Seifert HA, Gross JB. A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study. Gastrointest Endosc 1999; 49:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/26\">",
"      Scholer SG, Schafer DF, Potter JF. The effect of age on the relative potency of midazolam and diazepam for sedation in upper gastrointestinal endoscopy. J Clin Gastroenterol 1990; 12:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/27\">",
"      Bell GD, Spickett GP, Reeve PA, et al. Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol 1987; 23:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/28\">",
"      Robertson DJ, Jacobs DP, Mackenzie TA, et al. Clinical trial: a randomized, study comparing meperidine (pethidine) and fentanyl in adult gastrointestinal endoscopy. Aliment Pharmacol Ther 2009; 29:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/29\">",
"      ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2012; 76:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/30\">",
"      Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg 1970; 49:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24936/abstract/31\">",
"      Chung F, Chan VW, Ong D. A post-anesthetic discharge scoring system for home readiness after ambulatory surgery. J Clin Anesth 1995; 7:500.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2567 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-E85F879F22-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24936=[""].join("\n");
var outline_f24_22_24936=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREPROCEDURE PREPARATION AND ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LEVELS OF SEDATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SUPPLEMENTAL OXYGEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SEDATIVES AND ANALGESICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Choice of medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Patient-related considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Procedure-related considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pharyngeal anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Intravenous agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Benzodiazepines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Opiates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Propofol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREGNANCY AND LACTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      POST-PROCEDURE MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2567\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2567|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/36/2626\" title=\"figure 1\">",
"      Modified Mallampati airway classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2567|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/33/8733\" title=\"table 1\">",
"      American Society of Anesthesiologists physical status scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/6/32877\" title=\"table 2\">",
"      Meds for conscious sedation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=related_link\">",
"      Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=related_link\">",
"      Carbon dioxide monitoring (capnography)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/41/28310?source=related_link\">",
"      Complications of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/30/9698?source=related_link\">",
"      Patient information: Colonoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/11/18611?source=related_link\">",
"      Patient information: Colonoscopy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=related_link\">",
"      Sedation-free gastrointestinal endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_22_24937="Congenital neutropenia";
var content_f24_22_24937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital neutropenia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Thomas D Coates, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Laurence A Boxer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/22/24937/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/22/24937/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of neutropenia are acquired and are due to increased destruction, granulocyte apoptosis, or decreased granulocyte production. Less common are the congenital neutropenias, which will be discussed here. A general discussion of neutropenia is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the congenital conditions associated with neutropenia presented below, some of these disorders are discussed separately in more detail:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link\">",
"       \"Shwachman-Diamond syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"       \"Cyclic neutropenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42278?source=see_link\">",
"       \"Chediak-Higashi syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=see_link\">",
"       \"Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"       \"Primary humoral immune deficiencies: An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7992?source=see_link\">",
"       \"Cartilage-hair hypoplasia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12000362\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12000370\">",
"    <span class=\"h2\">",
"     Definition of neutropenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutropenia in the adult is defined as an absolute neutrophil count (ANC)",
"    <span class=\"nowrap\">",
"     &lt;1500/microL",
"    </span>",
"    (&lt;1.5 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L).",
"    </span>",
"    The ANC is equal to the product of the white blood cell count (WBC) and the fraction of polymorphonuclear cells (PMNs) and band forms noted on the differential analysis:",
"   </p>",
"   <p>",
"    &nbsp;ANC &nbsp;= &nbsp;WBC",
"    <span class=\"nowrap\">",
"     (cells/microL)",
"    </span>",
"    &nbsp;x &nbsp;percent (PMNs &nbsp;+ &nbsp;bands) &nbsp;&divide; &nbsp;100",
"   </p>",
"   <p>",
"    Neutrophilic metamyelocytes and younger forms are not included in this calculation. The risk of infection begins to increase at an ANC",
"    <span class=\"nowrap\">",
"     &lt;1000/microL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef63903 \" href=\"UTD.htm?10/19/10555\">",
"     table 1",
"    </a>",
"    )(",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?12/1/12305?source=see_link\">",
"     calculator 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Leukopenia and granulocytopenia are generally used interchangeably with neutropenia, although they are somewhat different. Leukopenia refers to a low WBC that may be due to lymphopenia as well as neutropenia, while granulocytopenia refers to a reduced number of granulocytes (neutrophils, eosinophils, and basophils).",
"   </p>",
"   <p>",
"    Agranulocytosis literally means the absence of granulocytes, but the term is often used to indicate severe neutropenia (ie, ANC",
"    <span class=\"nowrap\">",
"     &lt;200/microL).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12000377\">",
"    <span class=\"h2\">",
"     Definition of congenital neutropenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term &ldquo;congenital neutropenia&rdquo; is somewhat confusing in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1\">",
"     1",
"    </a>",
"    ]. &ldquo;Congenital&rdquo; neutropenia technically means any neutropenia present at or near birth, and thus would include transient immune neutropenias as well as inherited causes. We use the term to indicate neutropenia starting at or around birth and due to a primary bone marrow failure syndrome. The term &ldquo;congenital neutropenia&rdquo; primarily refers to severe congenital neutropenia (SCN), with the Kostmann Syndrome (HAX1 mutation) as one subtype. In a broader sense, cyclic neutropenia (CN) and Shwachman-Diamond Syndrome (SDS) are also included, although these disorders are usually referred to directly by their specific names (cyclic neutropenia, Shwachman-Diamond syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Both cyclic neutropenia and SDS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link\">",
"     \"Shwachman-Diamond syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to these disorders, there are now many recognized primary genetic defects that can result in serious chronic neutropenia with or without other immune deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,2,5\">",
"     1,2,5",
"    </a>",
"    ]. Most are characterized by a decreased bone marrow myeloid cell production, and an increased propensity to infection because of the resulting neutropenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cyclic neutropenia, in contrast to other congenital neutropenias, tends to be less severe than severe congenital neutropenia, but children with CN remain at risk for sepsis if not treated with G-CSF. During periods of neutropenia, patients with CN remain vulnerable to gingivitis and mouth ulcers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828169\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients present clinically with oropharyngeal problems, otitis media, respiratory infections, cellulitis, and skin infections, most often due to staphylococci and streptococci. Oral ulcerations and painful gingivitis are almost always present by two years of age in patients with severe neutropenia associated with decreased marrow reserve, although some children may also have stomatitis. Diffuse gastrointestinal lesions can give abdominal pain and diarrhea with a presentation mimicking Crohn&rsquo;s disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1\">",
"     1",
"    </a>",
"    ]. In comparison, infections with yeast, fungi, and parasites are infrequent in SCD, SDS, and CN since other immune functions are intact. While congenital neutropenia patients can become septic, the propensity to overwhelming infection is not as severe as is seen in post-chemotherapy neutropenia.",
"   </p>",
"   <p>",
"    Some patients have dysmorphic features or other associated physical findings as mentioned below [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/5\">",
"     5",
"    </a>",
"    ]. Hepatosplenomegaly and lymphadenopathy are generally not part of congenital neutropenia syndromes except as noted below [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/5\">",
"     5",
"    </a>",
"    ]. In general, any dysmorphic features in association with hematological findings of cytopenia should raise the questions of inherent marrow failure syndromes. Other clinical features of neutropenia with decreased marrow reserve are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12000400\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neutropenia seen in the congenital neutropenias begins in infancy and is associated with decreased production of myelocytes and cells beyond myelocytes. Affected patients usually have isolated neutropenia with an absolute neutrophil count (ANC)",
"    <span class=\"nowrap\">",
"     &lt;500/microL.",
"    </span>",
"    There may also be a relative monocytosis with monocyte percentage in the 30 to 50 percent range in some cases. At the time of the nadir of the neutrophil count in CN there is a reciprocal monocytosis.",
"   </p>",
"   <p>",
"    The hematologic presentations of these conditions are quite diverse. As an example, although all patients with SDS demonstrate varying degrees of bone marrow failure generally at an early age, some do not present until later in childhood, and approximately 10 percent do not have neutropenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link&amp;anchor=H7#H7\">",
"     \"Shwachman-Diamond syndrome\", section on 'Hematologic abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828195\">",
"    <span class=\"h2\">",
"     Bone marrow findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow aspiration can be helpful in the differential diagnosis of congenital neutropenia. Bone marrow examination in SCN characteristically shows normal or somewhat decreased cellularity with an early myeloid &ldquo;arrest&rdquo; at the",
"    <span class=\"nowrap\">",
"     promyelocyte/myelocyte",
"    </span>",
"    stage, often with atypical nuclei and cytoplasmic vacuolization. This bone marrow morphology is seen most typically in SCN due to mutations in ELANE, HAX1, WASP, G6PC3, and G-CSF receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,6-9\">",
"     1,6-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, the marrow in SDS, glycogen storage disease 1b, WHIM, Cohen disease, and Hermansky Pudlak syndrome type 2 is not characteristic, but usually is hypocellular with decreased myeloid precursors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1\">",
"     1",
"    </a>",
"    ]. Some patients with SDS have involvement of other cell lines as well [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/9\">",
"     9",
"    </a>",
"    ]. Bone marrow aspiration is not at all helpful in CN as the findings depend on when in the cycle the bone marrow is sampled. If done at the onset of neutropenia, it is similar to SCN.",
"   </p>",
"   <p>",
"    Some of the disorders noted below are T cell or B cell defects that result in neutropenia, often on an autoimmune basis, although a component of bone marrow failure may also be present. The bone marrow in antibody-mediated neutropenia will usually show normal cellularity with a late myeloid arrest or appear normal with neutrophils present or even increased. T cell disorders may show decreased marrow reserve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42520?source=see_link\">",
"     \"Immune neutropenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12000452\">",
"    <span class=\"h2\">",
"     Diagnostic features and making the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of the congenital neutropenias can be guided by the presence of various clinical and laboratory features listed below. However, the final diagnosis in most cases rests on identification of the gene mutation and results of the bone marrow examination.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Oculocutaneous albinism, peripheral neuropathy, and large granules in leukocytes  Chediak-Higashi Syndrome",
"     </li>",
"     <li>",
"      Metaphyseal dysplasia, pancreatic insufficiency  Shwachman-Diamond syndrome",
"     </li>",
"     <li>",
"      Oculocutaneous albinism  Griscelli syndrome, Hermansky-Pudlak syndrome, p14 deficiency",
"     </li>",
"     <li>",
"      Significant splenomegaly  Autoimmune lymphoproliferative syndrome, ALPS",
"     </li>",
"     <li>",
"      Warts  WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis syndrome)",
"     </li>",
"     <li>",
"      Monocytopenia, mild chronic neutropenia, and recurrent mycobacterial infections  MonoMAC syndrome",
"     </li>",
"     <li>",
"      Cyclic neutropenia  Cyclic neutropenia",
"     </li>",
"     <li>",
"      Hypoglycemia, growth retardation, hepatomegaly  Glycogen storage disease IB",
"     </li>",
"     <li>",
"      Short-limbed short stature, hypoplastic hair  Cartilage hair hypoplasia",
"     </li>",
"     <li>",
"      Skeletal myopathy, dilated cardiomyopathy  Barth&rsquo;s syndrome",
"     </li>",
"     <li>",
"      Hypotonia, microcephaly, mental retardation  Cohen syndrome",
"     </li>",
"     <li>",
"      Cardiac and urogenital malformations, neurologic disorders  Glucose 6 phosphatase, catalytic subunit 3 (G6PC3) syndrome (but the phenotype is highly variable [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/10\">",
"       10",
"      </a>",
"      ])",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SEVERE CONGENITAL NEUTROPENIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828389\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe congenital neutropenia (SCN) is rare, with an estimated frequency of two cases per million population. There is no particular gender predilection. At least based on data from the United States, the majority of patients are Caucasian [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,4,6,11,12\">",
"     1,4,6,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828432\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetics of SCN are heterogeneous and depend upon the specific gene defect, as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      SCN due to ELANE mutations is an autosomal dominant condition and occurs in 60 percent of patients.",
"     </li>",
"     <li>",
"      The initial family described by Kostmann, as well as other more recently described kindreds, have mutations in HAX1 with autosomal recessive inheritance [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/13-15\">",
"       13-15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      X-linked inheritance is seen in SCN due to mutations in the WASP gene [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,5\">",
"       1,5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mutations in the GATA2 transcription factor have been reported in seven families with autosomal dominant neutropenia [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/16\">",
"       16",
"      </a>",
"      ]. These GATA2 mutations were associated with a high incidence of acute myeloid leukemia within the family, warts, or the monoMAC syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/33/35354?source=see_link&amp;anchor=H15#H15\">",
"       \"Pathogenesis of acute myeloid leukemia\", section on 'Familial disorders leading to AML'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H430729017\">",
"       'WHIM syndrome'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link&amp;anchor=H3663155#H3663155\">",
"       \"Mendelian susceptibility to mycobacterial diseases (MSMD)\", section on 'GATA2 deficiency (MonoMAC syndrome)'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1828441\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe congenital neutropenia (SCN) presents in infancy with an average ANC",
"    <span class=\"nowrap\">",
"     &lt;200/microL",
"    </span>",
"    and often with elevated numbers of monocytes. There are no characteristic dysmorphic features. The clinical presentation has been described above. Other clinical features of SCN related to specific gene mutations are noted above.",
"   </p>",
"   <p>",
"    The primary clinical feature in SCN is propensity to infection. In the original description by Kostmann, 11 of the 14 patients died before their first birthday [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/17\">",
"     17",
"    </a>",
"    ]. Later follow up of this same cohort showed improved survival but development of neurological symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/18\">",
"     18",
"    </a>",
"    ]. The prognosis is now significantly better because of treatment with G-CSF. This agent results in improvement in the granulocyte counts in over 90 percent of patients. However, now that the patients are surviving into adulthood, it is clear that malignant transformation is a significant factor in overall survival.",
"   </p>",
"   <p>",
"    Data from the Severe Chronic Neutropenia International Registry indicated a sepsis mortality of approximately 0.81 percent annually (95% CI 0.56&ndash;1.16). The hazard of",
"    <span class=\"nowrap\">",
"     MDS/AML",
"    </span>",
"    is 2.3 percent per year (95% CI 1.7&ndash;2.9%). After 15 years treatment with G-CSF, the cumulative incidence of death from sepsis was 10 percent (95% CI 6-14%) and 22 percent for",
"    <span class=\"nowrap\">",
"     MDS/AML",
"    </span>",
"    (95% CI 17-28%) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of the neutropenia in SCN is known to be due to increased apoptosis of myeloid cells [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,4,20,21\">",
"     1,4,20,21",
"    </a>",
"    ]. SCN is a genetically transmitted disorder with recessive, dominant, or X-linked inheritance depending on which mutation is responsible. These mutations are ultimately associated with excessive apoptosis in myeloid precursors, probably due to activation of the unfolded protein response [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/34/25129?source=see_link\">",
"     \"Overview of hematopoiesis and stem cell function\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathogenesis of SCN from a historical and molecular basis has been reviewed, delineating the progression in our understanding of SCN in parallel with advances in understanding of the process of granulocyte differentiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,4,11\">",
"     1,4,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It was originally suggested that the defect in SCN resulted from mutations in the G-CSF receptor gene, resulting in a truncated receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/24\">",
"     24",
"    </a>",
"    ]. However, subsequent study revealed that this mutation is an acquired somatic mutation that may be associated with the development of acute leukemia (see below), but is clearly not the underlying basis for the disease itself.",
"   </p>",
"   <p>",
"    The mutation in the original kindred described by Kostmann is in HAX-1 and is recessively transmitted. The HAX-1 (HCLS1-associated X1) gene is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells. A recurrent homozygous germline mutation in HAX-1 has been found in a number of affected individuals with autosomal",
"    <strong>",
"     recessive",
"    </strong>",
"    severe congenital neutropenia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/13-15,25,26\">",
"     13-15,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first mutations identified in SCN were in the neutrophil elastase gene (ELANE, formerly termed ELA2). To date, there are over 100 mutations identified based on data from the Severe Chronic Neutropenia International Registry. There are several reports of mutations of the gene for neutrophil elastase in patients with SCN [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/27-32\">",
"     27-32",
"    </a>",
"    ]. In a study of 25 patients with congenital neutropenia, 22 had 18 different heterozygous mutations of the gene for neutrophil elastase; mutations were not found in three patients with Shwachman-Diamond syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The genetic defects of SCN and other congenital neutropenias have been recently reviewed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,4,33\">",
"     1,4,33",
"    </a>",
"    ]. Mutations in other genes have also been associated with SCN, though neutrophil elastase mutations account for 50 to 60 percent of cases of SCN [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/2,7,34-37\">",
"     2,7,34-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations other than those of neutrophil elastase and HAX-1 have been described in patients with SCN, including G6PC3, GFI1, SBDS, and WAS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/33,38\">",
"     33,38",
"    </a>",
"    ]. However, in approximately 40 percent of the cases, the genetic basis remains unknown.",
"   </p>",
"   <p>",
"    In reports of eight patients who were conceived from the same sperm donor, all children had the same mutation of ELANE (fourth exon at site S97L) and none of the mothers had an ELANE mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/31,39\">",
"     31,39",
"    </a>",
"    ]. Linkage analysis confirmed that all affected children had the same paternal allele leading to the expression of SCN, supporting the autosomal dominant inheritance of ELANE mutations.",
"   </p>",
"   <p>",
"    The expression of neutropenia in SCN and cyclic neutropenia may be either homogeneous or variable, according to the type of mutation and the genetic background, suggesting different pathogenetic mechanisms or, more likely, the effects of interacting genes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/30,39\">",
"     30,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link&amp;anchor=H3#H3\">",
"     \"Cyclic neutropenia\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729003\">",
"    <span class=\"h2\">",
"     Shwachman-Diamond Syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The triad of neutropenia, metaphyseal dysplasia, and pancreatic insufficiency is known as the Shwachman-Diamond (or Shwachman-Bodian-Diamond or Shwachman-Diamond-Oski) syndrome. This disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link\">",
"     \"Shwachman-Diamond syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729010\">",
"    <span class=\"h2\">",
"     Myelokathexis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of patients have been described with severe recurrent infections, neutropenia, and dysmyelopoietic features [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. These patients are often severely neutropenic although the bone marrow may be hypercellular, suggesting impaired release of neutrophils from the bone marrow. Many cells in the marrow are hypersegmented with abnormally long chromatin filaments connecting the nuclear lobes, have an unusual shape, and contain degenerative pyknotic nuclei and cytoplasmic vacuoles (ie, myelokathexis) (",
"    <a class=\"graphic graphic_picture graphicRef78993 \" href=\"UTD.htm?29/7/29809\">",
"     picture 1",
"    </a>",
"    ). The neutrophils demonstrate accelerated apoptosis, which may result from defective expression of Bcl-x, an inhibitor of apoptosis, in myeloid precursors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/45\">",
"     45",
"    </a>",
"    ]. Some patients also have nuclear abnormalities in peripheral blood neutrophils, and abnormalities in phagocytosis, chemotaxis, and the respiratory burst.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729017\">",
"    <span class=\"h3\">",
"     WHIM syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myelokathexis may be part of the WHIM syndrome (",
"    <strong>",
"     W",
"    </strong>",
"    arts,",
"    <strong>",
"     H",
"    </strong>",
"    ypogammaglobulinemia,",
"    <strong>",
"     I",
"    </strong>",
"    nfections,",
"    <strong>",
"     M",
"    </strong>",
"    yelokathexis), in which a mutation leads to the production of a mutant CXCR4 chemokine receptor that causes abnormal apoptosis and migratory function.",
"   </p>",
"   <p>",
"    The disease may be more common in females and, in several reports, has affected multiple members of the family, suggesting dominant inheritance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/36/31303?source=see_link&amp;anchor=H12#H12\">",
"     \"Definition and mechanisms of leukocytosis and neutrophilia\", section on 'WHIM syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment with G-CSF or GM-CSF has led to rapid mobilization of bone marrow neutrophils and improved myeloid morphologic features [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Associated defects in neutrophil motility and function in one patient were unaffected, but the patient improved clinically. The CXCR4 antagonist",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/12/27844?source=see_link\">",
"     plerixafor",
"    </a>",
"    also shows activity for treatment of the syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729458\">",
"    <span class=\"h2\">",
"     MonoMAC syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The &ldquo;monoMAC&rdquo; syndrome may be associated with mild chronic neutropenia (median ANC 1500), although persistent severe monocytopenia (absolute monocyte count &lt;200) is the hallmark of the disorder. It is autosomal dominant in inheritance and due to mutations in the GATA2 transcription factor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link&amp;anchor=H3663155#H3663155\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\", section on 'GATA2 deficiency (MonoMAC syndrome)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729024\">",
"    <span class=\"h2\">",
"     Chediak-Higashi syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chediak-Higashi syndrome (CHS) is a rare inherited disorder characterized by oculocutaneous albinism, progressive peripheral neuropathy, frequent neutropenia, and a tendency to develop life-threatening hemophagocytic lymphohistiocytosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=see_link\">",
"     \"Hemophagocytic lymphohistiocytosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42278?source=see_link\">",
"     \"Chediak-Higashi syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729031\">",
"    <span class=\"h2\">",
"     Glycogen storage disease type 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycogen storage disease (GSD) type 1, also known as von Gierke disease, is caused by a deficiency in microsomal glucose-6-phosphatase (G6P-ase) activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=see_link\">",
"     \"Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)\"",
"    </a>",
"    .) There are four subgroups: 1a, 1b, 1c, and 1d. Type 1a results from mutations in the G6P-ase gene on chromosome 17, while the defective gene for types 1b and 1c map to chromosome 11q23 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neutropenia occurs in types 1b and 1c, but only patients with type 1b suffer infectious complications, which are due to functional neutrophil deficiency, neutropenia, and the presence of circulating apoptotic neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. It has been suggested that microsomal glucose-6-phosphate transport has a role in the antioxidant protection of neutrophils, and that the genetic defect of the transporter leads to impaired neutrophil cellular function and apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729038\">",
"    <span class=\"h2\">",
"     Congenital cobalamin deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of inherited defects that interfere with the normal absorption, subsequent cellular processing, and transport of cobalamin (vitamin B12) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/56\">",
"     56",
"    </a>",
"    ]. All are associated with the presence of megaloblastic anemia typical of pernicious anemia, usually with mild degrees of neutropenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H430729045\">",
"    <span class=\"h2\">",
"     Immunologic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutropenia is seen in approximately 25 percent of patients with X-linked agammaglobulinemia and some patients with the hyperimmunoglobulin M syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/57\">",
"     57",
"    </a>",
"    ]. Many patients with these disorders benefit from the use of intravenous immune globulin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neutropenia is also a feature of reticular dysgenesis, a form of severe combined immunodeficiency characterized by absence of all leukocytes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link&amp;anchor=H13#H13\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\", section on 'Reticular dysgenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     G-CSF receptor mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although germline G-CSF receptor (CSF3R) mutations do not appear to play a major role in the development of neutropenia in SCN, acquired CSF3R mutations may contribute to the development of",
"    <span class=\"nowrap\">",
"     AML/MDS,",
"    </span>",
"    although the pathogenesis of",
"    <span class=\"nowrap\">",
"     AML/MDS",
"    </span>",
"    in SCN is not well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/7,58,59\">",
"     7,58,59",
"    </a>",
"    ]. In three series, 11 of 15 patients with SCN who acquired a G-CSF receptor point mutation developed AML or MDS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/6,24\">",
"     6,24",
"    </a>",
"    ]. However, point mutations are neither a prerequisite nor a direct cause for AML or MDS since not all patients who develop AML have a mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/60\">",
"     60",
"    </a>",
"    ], a mutation can be present without AML [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/58\">",
"     58",
"    </a>",
"    ], or the mutation can spontaneously disappear [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/61\">",
"     61",
"    </a>",
"    ]. Mice with a \"knock-in\" mutation of the G-CSF receptor do not develop AML. It is possible that mutations in the G-CSF receptor predispose to AML via a resistance to apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/62\">",
"     62",
"    </a>",
"    ], allowing more time for a \"second hit\" mutation to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been speculated that G-CSF therapy might increase the risk of AML [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. This concern is heightened in patients harboring receptor mutations in light of the hyperproliferative response to G-CSF observed in mutant mice. At present, there is no evidence that treatment accelerates leukemic progression in the mutant mice. It is likely that G-CSF is not involved in the development of leukemia in these patients, since AML also occurs in those who are untreated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. In support of this hypothesis is the observation that none of the patients with cyclic or idiopathic neutropenia treated with G-CSF has developed MDS or AML [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/6,65\">",
"     6,65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the advent of recombinant G-CSF, patients were conventionally treated with antibiotics for specific infections. The administration of prophylactic antibiotics, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , was common. Most patients died at a relatively early age. Although hematopoietic cell transplantation is an effective therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/68\">",
"     68",
"    </a>",
"    ], most patients were too sick to tolerate the required conditioning regimen.",
"   </p>",
"   <p>",
"    The availability of G-CSF (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     filgrastim",
"    </a>",
"    , lenograstim) therapy has dramatically changed management, resulting in a significant reduction in infections and improvement in the quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/6,7,69-71\">",
"     6,7,69-71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A multicenter, phase III trial randomly assigned 123 severely neutropenic patients (60 with SCN) to either immediate treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     filgrastim",
"    </a>",
"    (3.45 to 11.5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day) or a four-month observation period followed by filgrastim treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/69\">",
"     69",
"    </a>",
"    ]. Among the 120 patients given filgrastim, 108 had a median absolute neutrophil count (ANC) greater than or equal to",
"    <span class=\"nowrap\">",
"     1500/microL,",
"    </span>",
"    four were partial responders, and eight failed to respond. Filgrastim therapy was associated with a reduction in the incidence and duration of infection-related events of approximately 50 percent.",
"   </p>",
"   <p>",
"    Patients involved in the phase",
"    <span class=\"nowrap\">",
"     I/II/III",
"    </span>",
"    trials were continued on long-term maintenance treatment and an international registry was established that had enrolled 374 patients with SCN through 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/6,19,72\">",
"     6,19,72",
"    </a>",
"    ]. The median dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     filgrastim",
"    </a>",
"    required to maintain an ANC greater than",
"    <span class=\"nowrap\">",
"     1500/microL",
"    </span>",
"    in patients with SCN was 5.6",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day, considerably higher than the doses required in patients with cyclic or idiopathic neutropenia. In comparison, GM-CSF is much less likely to raise the ANC, and may instead increase eosinophil and monocyte counts [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A response can be obtained in almost all patients, with most patients responding to a dose between 3 and 10",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day and fewer than 5 percent of patients not responding to 100",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. All responding patients have had reduced infections and a markedly improved quality of life. There have been few adverse effects other than splenomegaly, which occurred in 30 percent of patients; six patients underwent splenectomy for management of severe thrombocytopenia.",
"   </p>",
"   <p>",
"    The safety of chronic G-CSF administration continues to be an important issue. Two complications of concern are the development of malignancy (see above) and a high frequency of osteopenia and osteoporosis. Both appear to be complications of the underlying disease unmasked by the increased life duration with treatment. Patients with suboptimal responses to doses of G-CSF in excess of 6",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day had increased rates of sepsis mortality as well as",
"    <span class=\"nowrap\">",
"     MDS/AML",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/19\">",
"     19",
"    </a>",
"    ]. The very high doses of G-CSF generally occurred in those children with subnormal ANCs in an attempt to \"normalize\" their ANC and prevent infection. This resulted in a wide spectrum of doses ranging from 0.2 to 576",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day. Follow-up on the SCN registry indicates that patients who failed to achieve an ANC",
"    <span class=\"nowrap\">",
"     &gt;2188/microL",
"    </span>",
"    (2.188 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L)",
"    </span>",
"    in spite of G-CSF doses above 8",
"    <span class=\"nowrap\">",
"     mcg/kg/day",
"    </span>",
"    were at elevated risk of sepsis, death, and",
"    <span class=\"nowrap\">",
"     MDS/AML.",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients in the low risk group had a cumulative risk of sepsis death after 15 years on G-CSF of 5 percent (95% CI: 0-12%) and 15 percent (95% CI 4-25%) for",
"      <span class=\"nowrap\">",
"       MDS/AML.",
"      </span>",
"     </li>",
"     <li>",
"      For those requiring more than 8",
"      <span class=\"nowrap\">",
"       mcg/kg/day",
"      </span>",
"      G-CSF, there was an 18 percent (95% CI 7-28%) sepsis risk and 34 percent (95% CI 21-47%) for",
"      <span class=\"nowrap\">",
"       MDS/AML",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although treatment of SCN patients with an appropriate dose of G-CSF can reverse neutropenia and reduce the risk of sepsis, these patients are still at risk to succumb to sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/75\">",
"     75",
"    </a>",
"    ]. Death from sepsis in treated SCN patients may reflect myelosuppression by intercurrent illness or lapses in therapy due to non-adherence.",
"   </p>",
"   <p>",
"    Hematopoietic cell transplantation (HCT) is curative and should be considered for all patients, particularly those with a high requirement for G-CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/76-78\">",
"     76-78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A high incidence of bone loss has been found in patients treated with G-CSF for SCN [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. In one series, for example, bone mineral content was found to be significantly reduced in 15 of 30 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/79\">",
"     79",
"    </a>",
"    ] and is now known to be a side effect of G-CSF treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/22/24937/abstract/1,81\">",
"     1,81",
"    </a>",
"    ]. Accordingly, bone density, as well as 25-OH vitamin D levels should be monitored and osteoporosis treated as indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42519?source=see_link\">",
"     \"Bone physiology and biochemical markers of bone turnover\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23879341\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The term &ldquo;congenital neutropenia&rdquo; is used here to indicate neutropenia starting at or around birth, due to a primary bone marrow failure syndrome. It refers primarily to the following three conditions:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Severe congenital neutropenia (SCN) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Severe congenital neutropenia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Cyclic neutropenia (CN) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"       \"Cyclic neutropenia\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Shwachman-Diamond syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link\">",
"       \"Shwachman-Diamond syndrome\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are many additional primary genetic defects with serious chronic neutropenia with or without other immune deficiencies. Most are characterized by a decreased bone marrow reserve pool and an increased propensity to infection. (See",
"      <a class=\"local\" href=\"#H12000452\">",
"       'Diagnostic features and making the diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"       \"Overview of neutropenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with congenital neutropenias present clinically with oropharyngeal problems, otitis media, respiratory infections, cellulitis, and skin infections, most often due to staphylococci and streptococci. Oral ulcerations and painful gingivitis are almost always present by two years of age. (See",
"      <a class=\"local\" href=\"#H1828169\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with congenital neutropenias usually have isolated neutropenia with an absolute neutrophil count (ANC)",
"      <span class=\"nowrap\">",
"       &lt;500/microL.",
"      </span>",
"      Bone marrow examination in SCN characteristically shows normal or somewhat decreased cellularity with an early myeloid arrest at the",
"      <span class=\"nowrap\">",
"       promyelocyte/myelocyte",
"      </span>",
"      stage. (See",
"      <a class=\"local\" href=\"#H12000400\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1828195\">",
"       'Bone marrow findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of the congenital neutropenias may be guided by the presence of associated clinical features, although the final diagnosis rests on identification of the gene mutation and results of the bone marrow examination. (See",
"      <a class=\"local\" href=\"#H12000452\">",
"       'Diagnostic features and making the diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1828195\">",
"       'Bone marrow findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/1\">",
"      Donadieu J, Fenneteau O, Beaupain B, et al. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011; 6:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/2\">",
"      Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 2007; 49:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/3\">",
"      Bouma G, Ancliff PJ, Thrasher AJ, Burns SO. Recent advances in the understanding of genetic defects of neutrophil number and function. Br J Haematol 2010; 151:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/4\">",
"      Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol 2011; 29:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/5\">",
"      Rezaei N, Moazzami K, Aghamohammadi A, Klein C. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol 2009; 28:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/6\">",
"      Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 1997; 34:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/7\">",
"      Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009; 144:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/8\">",
"      Amato D, Freedman MH, Saunders EF. Granulopoiesis in severe congenital neutropenia. Blood 1976; 47:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/9\">",
"      Leguit RJ, van den Tweel JG. The pathology of bone marrow failure. Histopathology 2010; 57:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/10\">",
"      Boztug K, Rosenberg PS, Dorda M, et al. Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 2012; 160:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/11\">",
"      Berliner N. Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis. Blood 2008; 111:5427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/12\">",
"      Dale DC, Bolyard AA, Schwinzer BG, et al. The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Support Cancer Ther 2006; 3:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/13\">",
"      Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 2007; 39:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/14\">",
"      Smith BN, Ancliff PJ, Pizzey A, et al. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol 2009; 144:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/15\">",
"      Faiyaz-Ul-Haque M, Al-Jefri A, Al-Dayel F, et al. A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr 2010; 169:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/16\">",
"      Pasquet M, Bellann&eacute;-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 2013; 121:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/17\">",
"      KOSTMANN R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956; 45:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/18\">",
"      Kostmann R. Infantile genetic agranulocytosis: A review with presentation of 10 cases. Acta Pediatr Scand 1975; 64:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/19\">",
"      Rosenberg PS, Zeidler C, Bolyard AA, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010; 150:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/20\">",
"      Carlsson G, Aprikyan AA, Tehranchi R, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004; 103:3355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/21\">",
"      Dale DC. Cyclic and chronic neutropenia: an update on diagnosis and treatment. Clin Adv Hematol Oncol 2011; 9:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/22\">",
"      Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol 2008; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/23\">",
"      K&ouml;llner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 2006; 108:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/24\">",
"      Dong F, Dale DC, Bonilla MA, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997; 11:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/25\">",
"      Carlsson G, Melin M, Dahl N, et al. Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropenia. Acta Paediatr 2007; 96:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/26\">",
"      Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 2008; 111:4954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/27\">",
"      Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/28\">",
"      Horwitz M, Li FQ, Albani D, et al. Leukemia in severe congenital neutropenia: defective proteolysis suggests new pathways to malignancy and opportunities for therapy. Cancer Invest 2003; 21:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/29\">",
"      Ancliff PJ, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98:2645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/30\">",
"      Bellann&eacute;-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004; 103:4119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/31\">",
"      Boxer LA, Stein S, Buckley D, et al. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr 2006; 148:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/32\">",
"      Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007; 109:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/33\">",
"      Xia J, Bolyard AA, Rodger E, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009; 147:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/34\">",
"      Dale DC, Link DC. The many causes of severe congenital neutropenia. N Engl J Med 2009; 360:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/35\">",
"      Boztug K, Appaswamy G, Ashikov A, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 2009; 360:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/36\">",
"      Klein C, Welte K. Genetic insights into congenital neutropenia. Clin Rev Allergy Immunol 2010; 38:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/37\">",
"      Boztug K, Klein C. Genetic etiologies of severe congenital neutropenia. Curr Opin Pediatr 2011; 23:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/38\">",
"      McDermott DH, De Ravin SS, Jun HS, et al. Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood 2010; 116:2793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/39\">",
"      Newburger PE, Pindyck TN, Zhu Z, et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer 2010; 55:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/40\">",
"      ZUELZER WW. \"MYELOKATHEXIS\"--A NEW FORM OF CHRONIC GRANULOCYTOPENIA. REPORT OF A CASE. N Engl J Med 1964; 270:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/41\">",
"      O'Regan S, Newman AJ, Graham RC. 'Myelokathexis'. Neutropenia with marrow hyperplasia. Am J Dis Child 1977; 131:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/42\">",
"      Mamlok RJ, Juneja HS, Elder FF, et al. Neutropenia and defective chemotaxis associated with binuclear, tetraploid myeloid-monocytic leukocytes. J Pediatr 1987; 111:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/43\">",
"      Plebani A, Cant&ugrave;-Rajnoldi A, Collo G, et al. Myelokathexis associated with multiple congenital malformations: immunological study on phagocytic cells and lymphocytes. Eur J Haematol 1988; 40:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/44\">",
"      Rassam SM, Roderick P, al-Hakim I, Hoffbrand AV. A myelokathexis-like variant of myelodysplasia. Eur J Haematol 1989; 42:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/45\">",
"      Aprikyan AA, Liles WC, Park JR, et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 2000; 95:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/46\">",
"      Weston B, Axtell RA, Todd RF 3rd, et al. Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis. J Pediatr 1991; 118:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/47\">",
"      Wetzler M, Talpaz M, Kellagher MJ, et al. Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF. JAMA 1992; 267:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/48\">",
"      McDermott DH, Liu Q, Ulrick J, et al. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 2011; 118:4957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/49\">",
"      Dale DC, Bolyard AA, Kelley ML, et al. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood 2011; 118:4963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/50\">",
"      Fenske CD, Jeffery S, Weber JL, et al. Localisation of the gene for glycogen storage disease type 1c by homozygosity mapping to 11q. J Med Genet 1998; 35:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/51\">",
"      Annabi B, Hiraiwa H, Mansfield BC, et al. The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet 1998; 62:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/52\">",
"      Garty BZ, Douglas SD, Danon YL. Immune deficiency in glycogen storage disease type 1B. Isr J Med Sci 1996; 32:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/53\">",
"      McCawley LJ, Korchak HM, Douglas SD, et al. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res 1994; 35:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/54\">",
"      Kuijpers TW, Maianski NA, Tool AT, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 2003; 101:5021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/55\">",
"      Leuzzi R, B&aacute;nhegyi G, Kardon T, et al. Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 2003; 101:2381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/56\">",
"      Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr 1998; 157 Suppl 2:S60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/57\">",
"      Farrar JE, Rohrer J, Conley ME. Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 1996; 81:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/58\">",
"      Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 2007; 109:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/59\">",
"      Link DC, Kunter G, Kasai Y, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 2007; 110:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/60\">",
"      Ancliff PJ, Gale RE, Liesner R, et al. Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. Br J Haematol 2003; 120:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/61\">",
"      Bernard T, Gale RE, Evans JP, Linch DC. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol 1998; 101:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/62\">",
"      Hunter MG, Avalos BR. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival. Blood 2000; 95:2132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/63\">",
"      Beekman R, Valkhof MG, Sanders MA, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012; 119:5071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/64\">",
"      Smith OP, Reeves BR, Kempski HM, Evans JP. Kostmann's disease, recombinant HuG-CSF, monosomy 7 and MDS/AML. Br J Haematol 1995; 91:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/65\">",
"      Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000; 96:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/66\">",
"      Rosen RB, Kang SJ. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 1979; 94:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/67\">",
"      Gilman PA, Jackson DP, Guild HG. Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 1970; 36:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/68\">",
"      Rappeport JM, Parkman R, Newburger P, et al. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med 1980; 68:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/69\">",
"      Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81:2496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/70\">",
"      Welte K, Zeidler C, Reiter A, et al. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 1990; 75:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/71\">",
"      Carlsson G, Ahlin A, Dahll&ouml;f G, et al. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol 2004; 126:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/72\">",
"      Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996; 72:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/73\">",
"      Zeidler C, Boxer L, Dale DC, et al. Management of Kostmann syndrome in the G-CSF era. Br J Haematol 2000; 109:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/74\">",
"      Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol 2006; 43:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/75\">",
"      Donini M, Fontana S, Savoldi G, et al. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood 2007; 109:4716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/76\">",
"      Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/77\">",
"      Ferry C, Ouach&eacute;e M, Leblanc T, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 2005; 35:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/78\">",
"      Carlsson G, Winiarski J, Ljungman P, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia. Pediatr Blood Cancer 2011; 56:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/79\">",
"      Yakisan E, Schirg E, Zeidler C, et al. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). J Pediatr 1997; 131:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/80\">",
"      Fewtrell MS, Kinsey SE, Williams DM, Bishop NJ. Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor. Br J Haematol 1997; 97:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/22/24937/abstract/81\">",
"      Takamatsu Y, Simmons PJ, Moore RJ, et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 1998; 92:3465.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8373 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E9920BD3B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24937=[""].join("\n");
var outline_f24_22_24937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23879341\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12000362\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12000370\">",
"      Definition of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12000377\">",
"      Definition of congenital neutropenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828169\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12000400\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828195\">",
"      Bone marrow findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12000452\">",
"      Diagnostic features and making the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SEVERE CONGENITAL NEUTROPENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828389\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828432\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1828441\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729003\">",
"      Shwachman-Diamond Syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729010\">",
"      Myelokathexis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H430729017\">",
"      - WHIM syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729458\">",
"      MonoMAC syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729024\">",
"      Chediak-Higashi syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729031\">",
"      Glycogen storage disease type 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729038\">",
"      Congenital cobalamin deficiencies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H430729045\">",
"      Immunologic disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - G-CSF receptor mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23879341\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/8373\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/8373|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/7/29809\" title=\"picture 1\">",
"      Myelokathexis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/8373|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/19/10555\" title=\"table 1\">",
"      Neutropenia and infectious risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?12/1/12305?source=related_link\" title=\"calculator 1\">",
"      Calculator: Absolute neutrophil count",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42519?source=related_link\">",
"      Bone physiology and biochemical markers of bone turnover",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7992?source=related_link\">",
"      Cartilage-hair hypoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42278?source=related_link\">",
"      Chediak-Higashi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=related_link\">",
"      Cyclic neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/36/31303?source=related_link\">",
"      Definition and mechanisms of leukocytosis and neutrophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=related_link\">",
"      Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/5/41050?source=related_link\">",
"      Hemophagocytic lymphohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42520?source=related_link\">",
"      Immune neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=related_link\">",
"      Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/34/25129?source=related_link\">",
"      Overview of hematopoiesis and stem cell function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/33/35354?source=related_link\">",
"      Pathogenesis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=related_link\">",
"      Shwachman-Diamond syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_22_24938="Open oophorectomy a";
var content_f24_22_24938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69337%7EOBGYN%2F79076%7EOBGYN%2F58049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69337%7EOBGYN%2F79076%7EOBGYN%2F58049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Open oophorectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The round ligament is divided and the retroperitoneal space entered.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Open oophorectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After the ureter is identified, a window is created in the broad ligament and the ovarian vessels are doubly clamped and divided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Open oophorectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 434px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The infundibulopelvic ligament (ovarian vessels) is then doubly ligated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24938=[""].join("\n");
var outline_f24_22_24938=null;
var title_f24_22_24939="Diagnostic criteria for acute and recurrent pericarditis";
var content_f24_22_24939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64302&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64302&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for acute and recurrent pericarditis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Acute pericarditis (at least 2 criteria of 4):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typical pleuritic chest pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pericardial friction rub",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Suggestive electrocardiogram changes (typically widespread ST segment elevation, PR depression)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New or worsening pericardial effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recurrent pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Typical pleuritic chest pain plus at least one objective evidence of disease activity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pericardial rub",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ECG changes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        New or worsening pericardial effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elevation of markers of inflammation (elevation in white blood cell count, erythrocyte sedimentation rate, or C-reactive protein)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24939=[""].join("\n");
var outline_f24_22_24939=null;
var title_f24_22_24940="Criteria schwannomatosis";
var content_f24_22_24940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F57973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F57973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=12\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for the diagnosis of schwannomatosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Criteria for definite schwannomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        A. Age &gt;30 years and all of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Two or more nonintradermal schwannomas, at least one with histologic confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No evidence of vestibular tumor on high-quality MRI scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No known constitutional NF2 mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        B. One pathologically confirmed nonvestibular schwannoma plus a first-degree relative who meets above criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Criteria for possible schwannomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        A. Age &lt;30 years and all of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Two or more nonintradermal schwannomas, at least one with histologic confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No evidence of vestibular tumor on high quality MRI scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No known constitutional NF2 mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        B. Age &gt;45 years and all of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Two or more nonintradermal schwannomas, at least one with histologic confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No symptoms of 8th cranial nerve dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; No known constitutional NF2 mutation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C. Radiographic evidence of a nonvestibular schwannoma and first degree relative meeting criteria for definite schwannomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Criteria for segmental schwannomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for either definite or possible schwannomatosis and schwannomas limited to one limb or &le;5 contiguous spine segments",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis. Neurology 2005; 64:1838. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24940=[""].join("\n");
var outline_f24_22_24940=null;
var title_f24_22_24941="Time course bronchoconstriction";
var content_f24_22_24941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Exercise-induced bronchoconstriction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The time course of exercise-induced bronchoconstriction in an asthmatic patient in whom the FEV1 fell by more than 20 percent after cycling.",
"    <div class=\"footnotes\">",
"     FEV1: forced expiratory volume in&nbsp;one second.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24941=[""].join("\n");
var outline_f24_22_24941=null;
var title_f24_22_24942="Use of metered dose inhaler";
var content_f24_22_24942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72731&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Use of metered dose inhaler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 293px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient holds the MDI between the thumb and index finger and closes his mouth around the spacer's mouthpiece.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24942=[""].join("\n");
var outline_f24_22_24942=null;
var title_f24_22_24943="Hidden penis";
var content_f24_22_24943=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidden penis in a five month old infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Buried penis in a five-month-old infant. Although only tip of glans is visible, the entire penis easily emerges if skin is gently pushed down under the pubic bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Eroglu E, Bastian OW, Ozcan HC, et al. Buried penis after newborn circumcision. J Urol 2009; 181:1841. Copyright &copy; 2009. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_22_24943=[""].join("\n");
var outline_f24_22_24943=null;
